Professor Richard Gearry

2024

Journal - Research Article

Swaminathan, A., Borichevsky, G. M., Frampton, C. M., Day, A. S., Hampton, M. B., Kettle, A. J., & Gearry, R. B. (2024). Comparison of fecal calprotectin and myeloperoxidase in predicting outcomes in inflammatory bowel disease. Inflammatory Bowel Diseases. Advance online publication. doi: 10.1093/ibd/izae032

Journal - Research Other

Hakak, F., Patel, R. N., & Gearry, R. B. (2024). Telecare in gastroenterology: Within the COVID-19 pandemic and beyond. Alimentary Pharmacology & Therapeutics. Advance online publication. doi: 10.1111/apt.17956

Swaminathan, A., Day, A. S., & Gearry, R. B. (2024). Assessing disease severity in inflammatory bowel disease: Can we reliably encompass the full burden of illness? Digestive & Liver Disease. Advance online publication. doi: 10.1016/j.dld.2024.01.185

Conference Contribution - Published proceedings: Abstract

Mcnamara, J., Wilson, W., Pipicella, J. L., Ghaly, S., Gearry, R., Begun, J., … Schultz, M., … Connor, S. J. (2024). Fistulising Crohn's Disease in a large Australasian cohort: Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn's & Colitis, 18(Suppl. 1), P1129. doi: 10.1093/ecco-jcc/jjad212.1259

Barnett, M., Mcnamara, J., Wilson, W., Pipicella, J., Ghaly, S., Gearry, R., … Schultz, M., … Andrews, J. M. (2024). Dose escalated Ustekinumab in Inflammatory Bowel Disease: Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn's & Colitis, 18(Suppl. 1), P1012. doi: 10.1093/ecco-jcc/jjad212.1142

Alshiwanna, B., Mcnamara, J., Wilson, W., Pipicella, J. L., Ghaly, S., Gearry, R., … Schultz, M., … Andrews, J. M. (2024). Dose escalated Infliximab in Inflammatory Bowel Disease: Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn's & Colitis, 18(Suppl. 1), P1005. doi: 10.1093/ecco-jcc/jjad212.1135

Mcnamara, J., Alshiwanna, B., Wilson, W., Pipicella, J. L., Ghaly, S., Gearry, R., … Schultz, M., … Connor, S. J. (2024). Dose escalated vedolizumab in Inflammatory Bowel Disease: Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn's & Colitis, 18(Suppl. 1), P959. doi: 10.1093/ecco-jcc/jjad212.1089

Pipicella, J. L., McNamara, J., Wilson, W., Lynch, K., Walker, G., Begun, J., … Gearry, R., Schultz, M., … Connor, S. J. (2024). The real-world use of five-aminosalicylate (5ASA) treatment for Ulcerative Colitis in Australia and New Zealand: Crohn's Colitis Cure (CCC) data insights program. Journal of Crohn's & Colitis, 18(Suppl. 1), P880. doi: 10.1093/ecco-jcc/jjad212.1010

Mcnamara, J., Wilson, W., Pipicella, J. L., Ghaly, S., Gearry, R., Williams, A., … Schultz, M., … Andrews, J. M. (2024). The burden of mental health disease in people with inflammatory bowel disease: Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn's & Colitis, 18(Suppl. 1), P462. doi: 10.1093/ecco-jcc/jjad212.0592

Mcnamara, J., Wilson, W., Pipicella, J., Ghaly, S., Gearry, R., Begun, J., … Schultz, M., … Connor, S. J. (2024). Variation of outcomes in inflammatory bowel disease at ten Australasian centres: Crohn's Colitis Cure (CCC) Data Insights Program. Journal of Crohn's & Colitis, 18(Suppl. 1), P286. doi: 10.1093/ecco-jcc/jjad212.0416

2023

Journal - Research Article

Forbes, A. J., Frampton, C. M. A., Day, A. S., Kaplan, G. G., & Gearry, R. B. (2023). The epidemiology of inflammatory bowel disease in Oceania: A systematic review and meta-analysis of incidence and prevalence. Inflammatory Bowel Diseases. Advance online publication. doi: 10.1093/ibd/izad295

Swaminathan, A., Fulforth, J. M., Frampton, C. M., Borichevsky, G. M., Mules, T. C., Kilpatrick, K., … Gearry, R. B. (2023). The Disease Severity Index for inflammatory bowel disease is a valid instrument that predicts complicated disease. Inflammatory Bowel Diseases. Advance online publication. doi: 10.1093/ibd/izad294

Parry-Strong, A., Gearry, R., Merry, T. L., Weatherall, M., Davies, C., Worthington, A., Bishop, R., Wright, S. R., … Foster, M., & Krebs, J. (2023). A high quality Aotearoa New Zealand dietary pattern adapting a Mediterranean diet for metabolic health: A feasibility study. BMC Nutrition, 9, 146. doi: 10.1186/s40795-023-00805-x

Forbes, A. J., Frampton, C. M. A., Day, A. S., Vernon-Roberts, A., & Gearry, R. B. (2023). Descriptive epidemiology of paediatric inflammatory bowel disease in Oceania: A systematic review and meta-analysis. Journal of Pediatric Gastroenterology & Nutrition, 77(4), 512-518. doi: 10.1097/MPG.0000000000003900

Romano, D., Chesterman, S., Fuller-Tyszkiewicz, M., Evans, S., Dober, M., Gearry, R., … McCombie, A., … Mikocka-Walus, A. (2023). Feasibility, acceptability, and preliminary efficacy of acceptance commitment therapy for adults living with inflammatory bowel disease and distress. Inflammatory Bowel Diseases, izad122. Advance online publication. doi: 10.1093/ibd/izad122

Brown, S., Wall, C. L., Frampton, C., Gearry, R. B., & Day, A. S. (2023). The low FODMAP diet for Children with inflammatory bowel disease and overlapping functional gastrointestinal symptoms: A case series. Recent Progress in Nutrition, 3(2), 009. doi: 10.21926/rpn.2302009

Falvey, J., Frampton, C. M. A., Gearry, R. B., Hudson, B., & Whiteley, L. (2023). Incorporating faecal haemoglobin measurement using the faecal immunochemical test (FIT) in the referral, triage, and prioritisation pathway for patients with colorectal symptoms. New Zealand Medical Journal/Te ara tika o te hauora hapori, 136(1578), 55-76. Retrieved from https://journal.nzma.org.nz/

Mak, J. W. Y., Sun, Y., Limsrivilai, J., Abdullah, M., Kaibullayeva, J., Balderramo, D., … Gearry, R. B., … on behalf of the GIVES-21 Consortium. (2023). Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21^st century (GIVES-21). BMC Medical Research Methodology, 23, 129. doi: 10.1186/s12874-023-01944-2

Brown, S. C., Wall, C. L., Gearry, R. B., & Day, A. S. (2023). Exclusive enteral nutrition for the treatment of pediatric Crohn’s disease: The patient perspective. Pediatric Gastroenterology, Hepatology & Nutrition, 26(3), 165-172. doi: 10.5223/pghn.2023.26.3.165

Burisch, J., Zhao, M., Odes, S., De Cruz, P., Vermeire, S., Bernstein, C. N., … Gearry, R. B., … Munkholm, P. (2023). The cost of inflammatory bowel disease in high-income settings: A Lancet Gastroenterology & Hepatology commission. Lancet Gastroenterology & Hepatology. Advance online publication. doi: 10.1016/s2468-1253(23)00003-1

James, S. C., Fraser, K., Cooney, J., Günther, C. S., Young, W., Gearry, R. B., … Keenan, J. I., … Roy, N. C. (2023). Concentrations of plasma amino acids and neurotransmitters in participants with functional gut disorders and healthy controls. Metabolites, 13, 313. doi: 10.3390/metabo13020313

MacIntosh, A., Heenan, P. E., Wright-McNaughton, M., Frampton, C., Skidmore, P., Wall, C. L., … Roy, N. C., & Gearry, R. B. (2023). The relationship between fermentable carbohydrates and post-prandial bowel symptoms in patients with functional bowel disorders. Frontiers in Nutrition, 10, 1060928. doi: 10.3389/fnut.2023.1060928

Gearry, R., Fukudo, S., Barbara, G., Kuhn-Sherlock, B., Ansell, J., Blatchford, P., … Drummond, L. (2023). Consumption of 2 green kiwifruits daily improves constipation and abdominal comfort: Results of an international multicenter randomized controlled trial. American Journal of Gastroenterology. Advance online publication. doi: 10.14309/ajg.0000000000002124

Mules, T. C., Swaminathan, A., Hirschfeld, E., Borichevsky, G. M., Frampton, C. M., Day, A. S., & Gearry, R. B. (2023). The impact of disease activity on sexual and erectile dysfunction in patients with inflammatory bowel disease. Inflammatory Bowel Diseases, 29, 1244-1254. doi: 10.1093/ibd/izac204

Simon, M. H., Heenan, P. E., Frampton, C., Bayer, S., Keenan, J. I., de Boer, N. K., Roy, N. C., … Gearry, R. B. (2023). Economic living standard and abdominal pain mediate the association between functional gastrointestinal disorders and depression or anxiety. Neurogastroenterology & Motility, 35, e14465. doi: 10.1111/nmo.14465

Mortlock, S., Lord, A., Montgomery, G., Zakrzewski, M., Simms, L. A., Krishnaprasad, K., … Gearry, R. B., & Radford-Smith, G. L. (2023). An extremes of phenotype approach confirms significant genetic heterogeneity in patients with ulcerative colitis. Journal of Crohn's & Colitis, 17, 277-288. doi: 10.1093/ecco-jcc/jjac121

Buie, M. J., Quan, J., Windsor, J. W., Coward, S., Hansen, T. M., King, J. A., … Gearry, R. B., … on behalf of the Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) Research Group. (2023). Global hospitalization trends for Crohn's disease and ulcerative colitis in the 21st century: A systematic review with temporal analyses. Clinical Gastroenterology & Hepatology, 21, 2211-2221. doi: 10.1016/j.cgh.2022.06.030

Journal - Research Other

Lithander, F. E., Parry Strong, A., Braakhuis, A., Worthington, A., Foster, M., Rolleston, A., … Gearry, R., Weatherall, M., & Krebs, J. D. (2023). He Rourou Whai Painga, an Aotearoa New Zealand dietary pattern for metabolic health and whānau wellbeing: Protocol for a randomized controlled trial. Frontiers in Nutrition, 10, 1298743. doi: 10.3389/fnut.2023.1298743

Elford, A. T., Leong, R. T., Halmos, E. P., Morgan, M., Kilpatrick, K., Lewindon, P. J., Gearry, R. B., & Christensen, B. (2023). IBD barriers across the continents: A continent-specific analysis: Australasia. Therapeutic Advances in Gastroenterology. Advance online publication. doi: 10.1177/17562848231197509

Swaminathan, A., Frampton, C. M., Borichevsky, G. M., Kettle, A. J., & Gearry, R. B. (2023). Response to "Evaluating discriminative accuracy of biomarkers in relation to binary study outcomes: First validate, then celebrate?" Journal of Crohn's & Colitis, 17, 147-148. doi: 10.1093/ecco-jcc/jjac126

Conference Contribution - Published proceedings: Abstract

Tharakan, L., on behalf of HRWP Trial, Lovell, A., Liu, E., Lithander, F., Merry, T., Gearry, R., Krebs, J., & Braakhuis, A., on behalf of HRWP Trial (2023). The relationship between eating behaviour and metabolic health in Aotearoa New Zealand: Preliminary He Rourou Wai Painga (HRWP) Trial data. Clinical Nutrition ESPEN, 58, (pp. 635). doi: 10.1016/j.clnesp.2023.09.618

Brown, S. C., Whelan, K., Frampton, C., Wall, C. L., Gearry, R. B., & Day, A. S. (2023). Food-related quality of life in children and adolescents with Crohn Disease. Clinical Nutrition ESPEN, 58, (pp. 751). doi: 10.1016/j.clnesp.2023.10.015

McNamara, J., Ghaly, S., Pipicella, J., Wilson, W., Goodfellow, T., Cheema, M., … Gearry, R., … Forbes, A., … Connor, S. (2023). Variation of outcomes in inflammatory bowel disease at 10 Australian and New Zealand centers: Crohn’s Colitis Cure data insights program. Journal of Gastroenterology & Hepatology, 38(Suppl. 2), (pp. 168-169). doi: 10.1111/jgh.16291

McNamara, J., Pipicella, J., Ghaly, S., Gearry, R., Forbes, A., Begun, J., … Connor, S. (2023). The evolving role of technology in delivering consumer-centric care for inflammatory bowel disease: An Australasian experience with Crohn’s Colitis Care’s e-health consumer portal. Journal of Gastroenterology & Hepatology, 38(Suppl. 2), (pp. 166-167). doi: 10.1111/jgh.16291

McNamara, J., Wilson, W., Pipicella, J., Goodfellow, T., Haifer, C., Gearry, R., Forbes, A., … Andrews, J. (2023). Burden of mental health issues in people with inflammatory bowel disease in Australasia: Crohn’s Colitis Cure data insights program. Journal of Gastroenterology & Hepatology, 38(Suppl. 2), (pp. 165). doi: 10.1111/jgh.16291

McNamara, J., Wilson, W., Pipicella, J., Goodfellow, T., Kim, A., Gearry, R., Forbes, A., … Andrews, J. (2023). Burden of disease for inflammatory bowel disease in Australasia: Crohn’s Colitis Cure data insights program. Journal of Gastroenterology & Hepatology, 38(Suppl. 2), (pp. 164). doi: 10.1111/jgh.16291

McGrory, L., McNamara, J., Wilson, W., Goodfellow, T., Pipicella, J., Ng, W., … Gearry, R., Forbes, A., … Connor, S. (2023). Outcomes for people with inflammatory boweldisease receiving dose-escalated adalimumabtherapy: Crohn’s Colitis Cure data insights program. Journal of Gastroenterology & Hepatology, 38(Suppl. 2), (pp. 158). doi: 10.1111/jgh.16291

McNamara, J., Wilson, W., Pipicella, J., Ghaly, S., Gearry, R., Forbes, A., … Connor, S. (2023). Fistulizing Crohn’s disease in a large real-world cohort: Crohn’s Colitis Cure data insights program. Journal of Gastroenterology & Hepatology, 38(Suppl. 2), (pp. 158). doi: 10.1111/jgh.16291

Burisch, J., Zhao, M., Odes, S., De Cruz, P., Vermeire, S., Bernstein, C. N., … Gearry, R. B., … Munkholm, P. (2023). The costs of inflammatory bowel diseases in high-income settings. Journal of Crohn's & Colitis, 17(Suppl. 1), (pp. i983). doi: 10.1093/ecco-jcc/jjac190.0990

Wall, C., Glyn, T., Rowbotham, D., Haines, M., Bissett, I., Eglinton, T., & Gearry, R. (2023). Randomised feasibility study of preoperative medical nutrition therapy in adults undergoing surgery for Crohn's disease. Journal of Crohn's & Colitis, 17(Suppl. 1), (pp. i899). doi: 10.1093/ecco-jcc/jjac190.0899

Conference Contribution - Verbal presentation and other Conference outputs

Roy, N. C., Bayer, S., Maggo, J., Ng, H. M., Wall, C., Carco, C., … Gearry, R. B. (2023, August). Dietary interventions, digestive physiology, and microbiome modulation. Verbal presentation at the Queenstown Molecular Biology (QMB) Microbiomes Satellite, Queenstown, New Zealand.

Ombasa, L., Miller, J. C., Ware, L., Abbotts-Holmes, H., Gearry, R. B., Bayer, S. B., Schultz, M., … Highton, A. J., Costello, R. M., Frampton, C. M. A., … Houghton, L. A., & Roy, N. C. (2023, August). Study of mānuka honey for digestive health (SOOTHE). Verbal presentation at the Kai mō Aotearoa Food Science Meeting [Queenstown Molecular Biology (QMB) Satellite], Queenstown, New Zealand.

Silk, E. T., Bayer, S. B., Roy, N. C., Taylor, M. W., Foster, M., Vatanen, T., & Gearry, R. B. (2023, August). Diet and disparities in shaping Indigenous microbiomes: The unexplored Māori gut microbiome. Verbal presentation at the Queenstown Molecular Biology (QMB) Microbiomes Satellite, Queenstown, New Zealand.

Other Research Output

Gearry, R., Wall, C., & Frizelle, F. (2023, August). You are what you eat: Your gut, nutrition and the bowel. Public Talk Series: Celebrating 50 years of University of Otago, Christchurch, Otautahi, New Zealand. Retrieved from https://events.otago.ac.nz/christchurch50/youarewhatyoueat/Site/Register

2022

Journal - Research Article

O'Brien, L., Wall, C., Wilkinson, T. J., & Gearry, R. B. (2022). Chronic diarrhoea in older adults and the role of dietary interventions. Nutrition & Healthy Aging, 7, 39-50. doi: 10.3233/NHA-220152

Bayer, S. B., Heenan, P., Frampton, C., Wall, C. L., Drummond, L. N., Roy, N. C., & Gearry, R. B. (2022). Two gold kiwifruit daily for effective treatment of constipation in adults: A randomized clinical trial. Nutrients, 14, 4146. doi: 10.3390/nu14194146

Merry, T. L., Metcalf, P., Scragg, R., Gearry, R., Foster, M., & Krebs, J. D. (2022). Metabolic syndrome severity score (MetSSS) associates with metabolic health status in multi-ethnic Aotearoa New Zealand cohorts. Diabetes Research & Clinical Practice, 192, 110088. doi: 10.1016/j.diabres.2022.110088

Thwaites, P. A., Yao, C. K., Maggo, J., John, J., Chrimes, A. F., Burgell, R. E., … Gearry, R. B., … Gibson, P. R. (2022). Comparison of gastrointestinal landmarks using the gas-sensing capsule and wireless motility capsule. Alimentary Pharmacology & Therapeutics, 56, 1337-1348. doi: 10.1111/apt.17216

Brown, S., Wall, C. L., Frampton, C., Gearry, R. B., & Day, A. S. (2022). Dietary nutrient intake and blood micronutrient status of children with Crohn's disease compared with their shared-home environment, healthy siblings. Nutrients, 14, 3425. doi: 10.3390/nu14163425

Volkers, A. G., Appleton, L., Gearry, R. B., Frampton, C. M., De Voogd, F. A. E., Peters van Ton, A. M., … Day, A. S. (2022). Fecal calprotectin, chitinase 3-like-1, S100A12 and osteoprotegerin as markers of disease activity in children with Crohn's disease. Gastrointestinal Disorders, 4(3), 180-189. doi: 10.3390/gidisord4030017

Lo, B., Barreiro-de Acosta, M., Bernstein, C. N., Burisch, J., Ferreira, N., Gearry, R. B., … Knowles, S. R. (2022). Fear of COVID-19 among patients with inflammatory bowel disease as compared to patients with other gastrointestinal conditions. Turkish Journal of Gastroenterology, 33(8), 664-672. doi: 10.5152/tjg.2022.21774

Evans, S., Olive, L., Dober, M., Knowles, S., Fuller-Tyszkiewicz, M., O, E., … Gearry, R., McCombie, A., … Mikocka-Walus, A. (2022). Acceptance commitment therapy (ACT) for psychological distress associated with inflammatory bowel disease (IBD): Protocol for a feasibility trial of the ACTforIBD programme. BMJ Open, 12, e060272. doi: 10.1136/bmjopen-2021-060272

Swaminathan, A., Borichevsky, G. M., Edwards, T. S., Hirschfeld, E., Mules, T. C., Frampton, C. M. A., Day, A. S., Hampton, M. B., Kettle, A. J., & Gearry, R. B. (2022). Faecal myeloperoxidase as a biomarker of endoscopic activity in inflammatory bowel disease. Journal of Crohn's & Colitis, 16, 1862-1873. doi: 10.1093/ecco-jcc/jjac098

Ma, C., Hanzel, J., Panaccione, R., Sandborn, W. J., D'Haens, G. R., Ahuja, V., … Gearry, R. B., … Jairath, V. (2022). CORE-IBD: A multidisciplinary international consensus initiative to develop a core outcome set for randomized controlled trials in inflammatory bowel disease. Gastroenterology. doi: 10.1053/j.gastro.2022.06.068

Liu, Z., Julsgaard, M., Zhu, X., Martin, J., Barclay, M., Cranswick, N., … Gearry, R., … the CARINA Study Group. (2022). Timing of live attenuated vaccination in infants exposed to infliximab or adalimumab in utero: A prospective cohort study in 107 children. Journal of Crohn's & Colitis, 16, 1835-1844. doi: 10.1093/ecco-jcc/jjac093

Swaminathan, A., Fan, D., Borichevsky, G. M., Mules, T. C., Hirschfeld, E., Frampton, C. M., Day, A. S., … Gearry, R. B. (2022). The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease course. Alimentary Pharmacology & Therapeutics, 56, 664-674. doi: 10.1111/apt.17058

Falling, C. L., Stebbings, S., Baxter, G. D., Siegel, C. A., Gearry, R. B., & Mani, R. (2022). Somatosensory assessments in patients with inflammatory bowel disease: A cross-sectional study examining pain processing pathways and the role of multiple patient factors. European Journal of Gastroenterology & Hepatology, 34(5), 503-511. doi: 10.1097/meg.0000000000002354

Brown, S. C., Whelan, K., Frampton, C., Wall, C. L., Gearry, R. B., & Day, A. S. (2022). Food-related quality of life in children and adolescents with Crohn's disease. Inflammatory Bowel Diseases, 28, 1838-1843. doi: 10.1093/ibd/izac010

Kaplan, G. G., Underwood, F. E., Coward, S., Agrawal, M., Ungaro, R. C., Brenner, E. J., Gearry, R. B., … Colombel, J.-F. (2022). The multiple waves of COVID-19 in patients with inflammatory bowel disease: A temporal trend analysis. Inflammatory Bowel Diseases, 28, 1687-1695. doi: 10.1093/ibd/izab339

Mules, T. C., Swaminathan, A., Hirschfeld, E., Borichevsky, G., Frampton, C., Day, A. S., & Gearry, R. B. (2022). The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease-results from the Stress, Anxiety and Depression with Disease Activity (SADD) Study. Alimentary Pharmacology & Therapeutics, 55, 201-211. doi: 10.1111/apt.16616

Hayes, B., Apputhurai, P., Mikocka‑Walus, A., Barreiro‑de Acosta, M., Bernstein, C. N., Burgell, R., … Gearry, R., … Knowles, S. R. (2022). Extending the common sense model to explore the impact of the fear of COVID-19 on quality of life in an international inflammatory bowel disease cohort. Journal of Clinical Psychology in Medical Settings, 29, 678-688. doi: 10.1007/s10880-021-09823-y

Ungaro, R. C., Brenner, E. J., Agrawal, M., Zhang, X., Kappelman, M. D., Colombel, J.-F., Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD) Research Group, including Gearry, R. B. (2022). Impact of medications on COVID-19 outcomes in inflammatory bowel disease: Analysis of over 6,000 patients from an international registry. Gastroenterology, 162, 316-319. doi: 10.1053/j.gastro.2021.09.011

Mikocka-Walus, A., Skvarc, D., Barreiro de Acosta, M., Bennebroek Evertsz, F., Bernstein, C. N., Burisch, J., … Gearry, R. B., … Knowles, S. R. (2022). Exploring the relationship between self-isolation and distress among people with gastrointestinal disorders during the COVID-19 pandemic. Journal of Clinical Psychology in Medical Settings, 29, 654-665. doi: 10.1007/s10880-021-09818-9

Journal - Research Other

Swaminathan, A., Mules, T. C., & Gearry, R. B. (2022). Measuring disease severity in inflammatory bowel disease: The whole is greater than the sum of its parts: Authors' reply [Invited]. Alimentary Pharmacology & Therapeutics, 56, 746-747. doi: 10.1111/apt.17126

Qiu, M., Patel, R. N., Kerrison, C., & Gearry, R. B. (2022). Low but increasing rates of inflammatory bowel disease in Māori: A report from Lakes District Health Board IBD. New Zealand Medical Journal, 135(1555), 99-105. Retrieved from https://www.nzma.org.nz/journal

Bayer, S. B., Frampton, C. M., Gearry, R. B., & Barbara, G. (2022). Habitual green kiwifruit consumption is associated with a reduction in upper gastrointestinal symptoms: A systematic scoping review. Advances in Nutrition, 13, 846-856. doi: 10.1093/advances/nmac025

MacIsaac, M. B., Julsgaard, M., Flanagan, E., Rowe, S., Ross, A. L., Gearry, R. B., … Bell, S. J. (2022). Anti-TNFα induction therapy for patients with active inflammatory bowel disease during pregnancy: A case series. Inflammatory Bowel Diseases, 28, 652-655. doi: 10.1093/ibd/izab227

Fulforth, J., Gearry, R., on behalf of the CCNZ #wecantwait committee, including Stein, R., & McCombie, A. (2022). Inequitable access to IBD therapies extends beyond developing nations. Journal of Crohn's & Colitis, 16(1), 173-174. doi: 10.1093/ecco-jcc/jjab108

Conference Contribution - Published proceedings: Abstract

Falling, C., Stebbings, S., Baxter, G. D., Siegel, C. A., Gearry, R. B., & Mani, R. (2022). Assessment of central pain processing pathways in patients with inflammatory bowel disease. Proceedings of the New Zealand Pain Society (NZPS) Annual Scientific Meeting. Retrieved from https://www.nzps2022.nz

Wall, C., Glyn, T., Bissett, I., Rowbotham, D., Haines, M., Gearry, R., & Eglinton, T. (2022). Perioperative nutrition optimisation in nourished Crohn's disease patients: A feasibility randomised controlled trial. Colorectal Disease, 24(Suppl. 1), (pp. 144). doi: 10.1111/codi.16048

McCombie, A., Frampton, C., Salwen, J., Siegal, C., Hirschfeld, E., Hughes, H., … Gearry, R. (2022). How well do patient perceptions of severity correlate with the Inflammatory Bowel Disease Severity Score and what factors moderate this association? Colorectal Disease, 24(Suppl. 1), (pp. 35-36). doi: 10.1111/codi.16048

2021

Journal - Research Article

James, S. C., Fraser, K., Young, W., Heenan, P. E., Gearry, R. B., Keenan, J. I., … Roy, N. C. (2021). Concentrations of fecal bile acids in participants with functional gut disorders and healthy controls. Metabolites, 11, 612.

Vernon-Roberts, A., Lopez, R. N., Lewindon, P., Lemberg, D. A., Bowcock, N. L., Alex, G., … Gearry, R. B., & Day, A. S. (2021). Assessment of disease-related knowledge among children with inflammatory bowel disease and their family using IBD-KID2: Evaluating tool generalizability. JPGN Reports, 2(3), e093. doi: 10.1097/PG9.0000000000000093

Mikocka-Walus, A., Skvarc, D., van Tilburg, M. A. L., Barreiro-de Acosta, M., Bennebroek Evertsz, F., Bernstein, C. N., … Gearry, R. B., … Knowles, S. (2021). COVID-19-related personal product shortages are associated with psychological distress in people living with gastrointestinal disorders: A cross-sectional survey. Neurogastroenterology & Motility, e14198. doi: 10.1111/nmo.14198

Gatenby, G., Glyn, T., Pearson, J., Gearry, R., & Eglinton, T. (2021). The long-term incidence of dysplasia and colorectal cancer in a Crohn’s colitis population-based cohort. Colorectal Disease, 23, 2399-2406. doi: 10.1111/codi.15756

Gearry, R. B., McCombie, A. M., Vatn, M., Rubin, D. T., Steinwurz, F., Loftus, E. F., … the World Gastroenterology Organization. (2021). What are the most challenging aspects of inflammatory bowel disease? An international survey of gastroenterologists comparing developed and developing countries. Inflammatory Intestinal Diseases, 6(2), 78-86. doi: 10.1159/000512310

Falling, C., Stebbings, S., Baxter, G. D., Gearry, R. B., & Mani, R. (2021). Criterion validity and discriminatory ability of the central sensitization inventory short form in individuals with inflammatory bowel disease. Scandinavian Journal of Pain, 21(3), 577-585. doi: 10.1515/sjpain-2021-0021

O'Brien, L., Wall, C. L., Wilkinson, T. J., & Gearry, R. B. (2021). What are the pearls and pitfalls of the dietary management for chronic diarrhoea? Nutrients, 13, 1393. doi: 10.3390/nu13051393

Falling, C., Stebbings, S., Baxter, G. D., Siegel, C. A., Gearry, R. B., Nijs, J., & Mani, R. (2021). Symptoms of central sensitization in patients with inflammatory bowel diseases: A case-control study examining the role of musculoskeletal pain and psychological factors. Scandinavian Journal of Pain, 21(2). doi: 10.1515/sjpain-2020-0109

Ungaro, R. C., Brenner, E. J., Gearry, R. B., Kaplan, G. G., Kissous-Hunt, M., Lewis, J. D., … Kappelman, M. D. (2021). Effect of IBD medications on COVID-19 outcomes: Results from an international registry. Gut, 70, 725-732. doi: 10.1136/gutjnl-2020-322539

Vernon-Roberts, A., Frampton, C., Gearry, R. B., & Day, A. S. (2021). Development and validation of a self-management skills assessment tool for children with inflammatory bowel disease: The IBD-Skills Tasks and Abilities Record (IBD-STAR). Journal of Pediatric Gastroenterology & Nutrition, 72(1), 67-73. doi: 10.1097/MPG.0000000000002905

Bernstein, C. N., Ng, S. C., Banerjee, R., Steinwurz, F., Shen, B., Carbonnel, F., … Gearry, R., the IBD-Emerging Nations Consortium and the WGO IBD Task Force on COVID-19. (2021). Worldwide management of inflammatory bowel disease during the COVID-19 pandemic: An international survey. Inflammatory Bowel Diseases, 27(6), 836-847. doi: 10.1093/ibd/izaa202

Journal - Research Other

Mules, T. C., Swaminathan, A., & Gearry, R. B. (2021). Brain-gut research needs objective measures of disease activity and mental disorders: Authors' reply. Alimentary Pharmacology & Therapeutics, 54(10), 1361-1362. doi: 10.1111/apt.16649

Olivera, P. A., Zuily, S., Kotze, P. G., Regnault, V., Awadhi, S. A., Bossuyt, P., Gearry, R. B., … Peyrin-Biroulet, L. (2021). International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nature Reviews Gastroenterology & Heaptology, 18, 857-873. doi: 10.1038/s41575-021-00492-8

Vernon-Roberts, A., Gearry, R. B., & Day, A. S. (2021). Overview of self-management skills and associated assessment tools for children with inflammatory bowel disease. Gastrointestinal Disorders, 3(2), 61-77. doi: 10.3390/gidisord3020007

Fan, D., & Gearry, R. B. (2021). IBD medications during the COVID-19 pandemic-are they safe to use? [Invited]. Alimentary Pharmacology & Therapeutics, 54(2), 208-209. doi: 10.1111/apt.16459

Ferreira, N., Mikocka-Walus, A., van Tilburg, M. A. L., Graff, L. A., Apputhurai, P., Barreiro-de Acosta, M., … Gearry, R., & Knowles, S. R. (2021). The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study. Journal of Psychosomatic Research, 148, 110561. doi: 10.1016/j.jpsychores.2021.110561

John, R. A., & Gearry, R. B. (2021). Smoking cessation for patients with Crohn disease: Not just for the patient? Inflammatory Bowel Diseases, 27(3), 386-387. doi: 10.1093/ibd/izaa118

Conference Contribution - Published proceedings: Abstract

Borichevsky, G., Swaminathan, A., Edwards, T., Day, A., Hampton, M., Kettle, A., & Gearry, R. (2021). Faecal myeloperoxidase is a biomarker of endoscopically active inflammatory bowel disease. Proceedings of the 16th Congress of the Federation of Asian & Oceanic Biochemists & Molecular Biologists (FAOBMB). (pp. 234). Retrieved from https://www.faobmb2021.org

Pipicella, J. L., Vernon-Roberts, A., Walsh, A., Wierzbicki, A., Day, A., Carter, D. W., … Gearry, R., … Dutt, S. (2021). Using a consensus-based method to develop a novel paediatric-specific inflammatory bowel disease ehealth clinical management system. Gut, 70(Suppl. 2), (pp. A108-A109). doi: 10.1136/gutjnl-2021-IDDF.127

Diep Pham, H. T., Wall, C., Bayer, S., Blatchford, P., & Gearry, R. (2021). An increase in Mediterranean dietary score, through SunGold^® Kiwifruit, potentially improves mental wellbeing. Current Developments in Nutrition, 5(Suppl. 2), (pp. 401). doi: 10.1093/cdn/nzab038_013

Conference Contribution - Poster Presentation (not in published proceedings)

Falling, C., Stebbings, S., Baxter, G. D., Gearry, R., & Mani, R. (2021, August). Profiles of musculoskeletal pain in New Zealanders with inflammatory bowel diseases. Poster session presented at the New Zealand Rheumatology Association (NZRA) Annual Scientific Meeting, [Online].

2020

Journal - Research Article

Croese, J., Miller, G. C., Marquart, L., Llewellyn, S., Gupta, R., Becker, L., … Gearry, R. B., … Giacomin, P. R. (2020). Randomized, placebo controlled trial of experimental hookworm infection for improving gluten tolerance in celiac disease. Clinical & Translational Gastroenterology, 11, e00274. doi: 10.14309/ctg.0000000000000274

Ho, S. S., Wall, C., Gearry, R. B., Keenan, J., & Day, A. S. (2020). A pilot study evaluating novel urinary biomarkers for Crohn's disease. Inflammatory Intestinal Diseases, 5(4), 212-220. doi: 10.1159/000510682

Vernon-Roberts, A., Gearry, R. B., & Day, A. S. (2020). The level of public knowledge about inflammatory bowel disease in Christchurch, New Zealand. Inflammatory Intestinal Diseases, 5(4), 205-211. doi: 10.1159/000510071

Croese, J., Miller, G. C., Marquart, L., Llewellyn, S., Gupta, R., Becker, L., … Gearry, R. B., … Giacomin, P. R. (2020). Randomized, placebo controlled trial of experimental hookworm infection for improving gluten tolerance in celiac disase. Clinical & Translational Gastroenterology, 11, e00274. doi: 10.14309/ctg.0000000000000274

O'Brien, L., Skidmore, P., Wall, C., Wilkinson, T., Muir, J., Frampton, C., & Gearry, R. (2020). A low FODMAP diet is nutritionally adequate and therapeutically efficacious in community dwelling older adults with chronic diarrhoea. Nutrients, 12(10), 3002. doi: 10.3390/nu12103002

Heenan, P., Creemers, R. H., Sharma, S., Keenan, J., Bayer, S., Young, W., … Skidmore, P. M., … Roy, N., Gearry, R. B., & COMFORT Cohort Collaborators. (2020). Cohort profile: The Christchurch IBS cOhort to investigate Mechanisms FOr gut Relief and improved Transit (COMFORT). Inflammatory Intestinal Diseases, 5(3), 132-143. doi: 10.1159/000508160

Chan, D., Skidmore, P., O'Brien, L., Watson, S., & Gearry, R. (2020). A feasibility study investigating the impact of a dietitian-led low in fermentable oligosaccharide, disaccharide, monosaccharide and polyols diet group education programme with irritable bowel syndrome. New Zealand Medical Journal, 133(1522), 42-51. Retrieved from https://www.nzma.org.nz/journal

Vernon-Roberts, A., Gearry, R. B., & Day, A. S. (2020). Assessment of knowledge levels following an education program for parents of children with inflammatory bowel disease. Frontiers in Pediatrics, 8, 475. doi: 10.3389/fped.2020.00475

Hackett, R., Gearry, R., Ho, C., McCombie, A., Mackay, M., Murdoch, K., … Inns, S. (2020). New Zealand national audit of outpatient inflammatory bowel disease standards of care. Clinical & Experimental Gastroenterology, 13, 285-292. doi: 10.2147/CEG.S259790

Allez, M., Fleshner, P., Gearry, R., Lakatos, P. L., Rubin, D. T., on behalf of the International Organization for the Study of Inflammatory Bowel Disease. (2020). Care of the patient with IBD requiring hospitalization during the COVID-19 pandemic. Journal of Crohn's & Colitis, 14(Suppl. 3), S774-S779. doi: 10.1093/ecco-jcc/jjaa150

Wall, C. L., McCombie, A., Mulder, R., Day, A. S., & Gearry, R. B. (2020). Adherence to exclusive enteral nutrition by adults with active Crohn’s disease is associated with conscientiousness personality trait: A sub-study. Journal of Human Nutrition & Dietetics, 33(6), 752-757. doi: 10.1111/jhn.12787

Paulides, E., Daker, C., Frampton, C., Gearry, R. B., Eglinton, T., de Boer, N. K. H., … McCombie, A. M. (2020). Overcoming workplace disability in IBD patients: An observational study. Inflammatory Intestinal Diseases, 5(2), 84-92. doi: 10.1159/000506702

Glyn Mullaney, T., McCombie, A., Wakeman, C., Eglinton, T., & Gearry, R. (2020). Surveillance for dysplasia in patients with inflammatory bowel disease: An updated national survey of colonoscopic practice in New Zealand. New Zealand Medical Journal, 133(1517), 56-65. Retrieved from https://www.nzma.org.nz/journal

Appleton, L., Watt, E., Jagger, F., Hansen, R., Gearry, R. B., & Day, A. S. (2020). Associations between the presence of granulomata and disease phenotype and outcomes in children diagnosed with Crohn’s disease. Gastrointestinal Disorders, 2(2), 164-170. doi: 10.3390/gidisord2020017

Brenner, E. J., Ungaro, R. C., Gearry, R. B., Kaplan, G. G., Kissous-Hunt, M., Lewis, J. D., … Kappelman, M. D. (2020). Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: Results from an international registry. Gastroenterology, 159, 481-491. doi: 10.1053/j.gastro.2020.05.032

Lopez, R. N., McCombie, A., Gearry, R. B., & Day, A. S. (2020). Impact of a camp upon disease-specific knowledge and quality of life in children and adolescents with inflammatory bowel disease. Inflammatory Intestinal Diseases, 5, 65-69. doi: 10.1159/000505918

Vernon-Roberts, A., Otley, A., Frampton, C., Gearry, R. B., & Day, A. S. (2020). Validation of a revised knowledge assessment tool for children with inflammatory bowel disease (IBD-KID2). Inflammatory Intestinal Diseases, 5, 70-77. doi: 10.1159/000506200

Vernon-Roberts, A., Otley, A., Frampton, C., Gearry, R. B., & Day, A. S. (2020). Response pattern analysis of IBD-KID: A knowledge assessment tool for children with inflammatory bowel disease. Journal of Paediatrics & Child Health, 56(1), 155-162. doi: 10.1111/jpc.14547

Tranter-Entwistle, I., Mullaney, T. G., Noah, K., Pearson, J., Falvey, J., Gearry, R., & Eglinton, T. (2020). Long-term incidence of dysplasia and colorectal cancer in an ulcerative colitis population-based cohort. ANZ Journal of Surgery, 90, 821-825. doi: 10.1111/ans.15686

Daveson, A. J. M., Popp, A., Taavela, J., Goldstein, K. E., Isola, J., Truitt, K. E., … on behalf of the RESET CeD Study Group, including Gearry, R. (2020). Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet. GastroHep, 2, 22-30. doi: 10.1002/ygh2.380

Brown, S. C., Whelan, K., Gearry, R. B., & Day, A. S. (2020). Low FODMAP diet in children and adolescents with functional bowel disorder: A clinical case note review. JGH Open, 4, 153-159. doi: 10.1002/jgh3.12231

Falling, C. L., Stebbings, S., Baxter, G. D., Gearry, R. B., & Mani, R. (2020). Central sensitization inventory mediates the relationship between inflammatory bowel disease activity and worse musculoskeletal pain experiences. Pain Practice, 20(1), 24-33. doi: 10.1111/papr.12821

Julsgaard, M., Hvas, C. L., Gearry, R. B., Gibson, P. R., Fallingborg, J., Sparrow, M. P., … Bell, S. J. (2020). Anti-TNF therapy in pregnant women with inflammatory bowel disease: Effects of therapeutic strategies on disease behavior and birth outcomes. Inflammatory Bowel Diseases, 26(1), 93-102. doi: 10.1093/ibd/izz110

Journal - Research Other

McCombie, A., Arnold, M., O'Connor, M., Stein, R., Fulforth, J., Brown, B., & Gearry, R. (2020). Why does Pharmac neglect inflammatory bowel disease? New Zealand Medical Journal, 133(1527), 111-115. Retrieved from https://www.nzma.org.nz/journal

Carco, C., Young, W., Gearry, R. B., Talley, N. J., McNabb, W. C., & Roy, N. C. (2020). Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis. Frontiers in Cellular & Infection Microbiology, 10, 468. doi: 10.3389/fcimb.2020.00468

Benson-Pope, S., & Gearry, R. B. (2020). Social distancing during the COVID‐19 pandemic: IBD patients cannot stay at home forever. Alimentary Pharmacology & Therapeutics, 52(4), 717-718. doi: 10.1111/apt.15874

Benson-Pope, S. J., & Gearry, R. B. (2020). Increasing IBD prevalence and its complications in the context of the COVID-19 pandemic. Alimentary Pharmacology & Therapeutics, 51(12), 1441-1442. doi: 10.1111/apt.15759

Benson-Pope, S. J., & Gearry, R. B. (2020). Better outcomes for Crohn's disease: More than just the drugs? [Invited]. Alimentary Pharmacology & Therapeutics, 51, 167-168. doi: 10.1111/apt.15543

Heenan, P. E., Keenan, J. I., Bayer, S., Simon, M., & Gearry, R. B. (2020). Irritable bowel syndrome and the gut microbiota. Journal of the Royal Society of New Zealand, 50(3), 470-490. doi: 10.1080/03036758.2019.1695635

Conference Contribution - Published proceedings: Abstract

Heenan, P., Frampton, C., Young, W., Roy, N., Keenan, J., Wall, C., … Gearry, R. (2020). Gastrointestinal and mental health symptoms group participants in an irritable bowel syndrome cohort. Journal of Gastroenterology & Hepatology, 35, (pp. 173). doi: 10.1111/jgh.15273

Mules, T., Stedman, C. A., Ding, S., Burt, M., Gearry, R., Chalmers-Watson, T., Falvey, J., Chapman, B., Barclay, M. L., Lim, G., … Ngu, J. H. (2020). The ABC score accurately predicts mortality in hospitalized patients that develop upper gastrointestinal bleeding. Gastrointestinal Endoscopy, 91(6, Suppl.), (pp. AB590-AB591). doi: 10.1016/j.gie.2020.03.3668

Roy, N., Heenan, P., Wall, C., Young, W., Carco, C., Keenan, J., … Gearry, R. (2020). Association of habitual dietary fiber intake and fecal microbiome gene abundance with gastrointestinal symptoms in an irritable bowel syndrome cohort. Current Developments in Nutrition, 4(Suppl. 2), (pp. 1581). doi: 10.1093/cdn/nzaa062_038

Wall, C., McCombie, A., Mulder, R., Day, A., & Gearry, R. (2020). Adherence to enteral nutrition therapy by adults with active Crohn's disease is associated with conscientiousness personality trait. Journal of Crohn's & Colitis, 14(Suppl. 1), (pp. S406-S407). doi: 10.1093/ecco-jcc/jjz203.584

Wall, C., MacFarlane, K., Carr, A., Day, A., & Gearry, R. (2020). Inadequate vitamin C status and association with inflammatory biomarkers in adults with active Crohn's disease. Journal of Crohn's & Colitis, 14(Suppl. 1), (pp. S465-S466). doi: 10.1093/ecco-jcc/jjz203.675

2019

Journal - Research Article

Wright-McNaughton, M., ten Bokkel Huinink, S., Frampton, C. M. A., McCombie, A. M., Talley, N. J., Skidmore, P. M. L., & Gearry, R. B. (2019). Measuring diet intake and gastrointestinal symptoms in irritable bowel syndrome: Validation of the Food and Symptom Times diary. Clinical & Translational Gastroenterology, 10, e00103. doi: 10.14309/ctg.0000000000000103

Daveson, A. J. M., Tye-Din, J. A., Goel, G., Goldstein, K. E., Hand, H. L., Neff, K. M., … on behalf of the RESET CeD Study Group, including Gearry, R. (2019). Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Alimentary Pharmacology & Therapeutics, 51(2), 244-252. doi: 10.1111/apt.15551

Nanayakkara, W. S., Skidmore, P., O'Brien, L., Wilkinson, T., Frampton, C., & Gearry, R. (2019). From menu to mouth: The decay pathway of nutrient intake from planned menu to consumed and characteristics of residents in an aged care facility with greater nutrient decay rates: A cross-sectional study. BMJ Open, 9(10), e024044. doi: 10.1136/bmjopen-2018-024044

Romagnoni, A., Jégou, S., Van Steen, K., Wainrib, G., Hugot, J.-P., and International Inflammatory Bowel Disease Genetics Constortium (IIBDGC), including Barclay, M., Gearry, R., & Roberts, R. L. (2019). Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data. Scientific Reports, 9, 10351. doi: 10.1038/s41598-019-46649-z

Gearry, R. B., Frampton, C., Inns, S., Poppelwell, D., Rademaker, M., & Suppiah, R. (2019). VITALITY: Impact of adalimumab on health and disability outcomes in patients with Crohn's disease, rheumatoid arthritis, or psoriasis treated in clinical practice in New Zealand. Current Medical Research & Opinion, 35(10), 1837-1846. doi: 10.1080/03007995.2019.1634952

Lamba, M., Alamri, Y., Garg, P., Frampton, C., Rowbotham, D., & Gearry, R. (2019). Predictors of non-attendance at outpatient endoscopy: A five-year multi-centre observational study from New Zealand. New Zealand Medical Journal, 132(1496), 31-38. Retrieved from https://www.nzma.org.nz/journal

Wall, C. L., McCombie, A. M., Gearry, R. B., & Day, A. S. (2019). Newly diagnosed Crohn's disease treated with standard care or enteral nutrition: Psychological outcomes over 6 months. Inflammatory Intestinal Diseases, 4(1), 7-13. doi: 10.1159/000497323

Eady, S. L., Wallace, A. J., Butts, C. A., Hedderley, D., Drummond, L., Ansell, J., & Gearry, R. B. (2019). The effect of ‘Zesy002’ kiwifruit (Actinidia chinensis var. chinensis) on gut health function: A randomised cross-over clinical trial. Journal of Nutritional Science, 8, e18. doi: 10.1017/jns.2019.14

Vernon-Roberts, A., Lopez, R. N., Frampton, C., Gearry, R. B., Lemberg, D. A., & Day, A. S. (2019). A symptom self-report tool for children with inflammatory bowel disease (IBDnow). Journal of Pediatric Gastroenterology & Nutrition, 69(1), e7-e12. doi: 10.1097/MPG.0000000000002329

Falling, C., Stebbings, S., Baxter, G. D., Gearry, R. B., & Mani, R. (2019). Musculoskeletal pain in individuals with inflammatory bowel disease reflects three distinct profiles. Clinical Journal of Pain, 35, 559-568. doi: 10.1097/ajp.0000000000000698

Paulides, E., Gearry, R. B., de Boer, N. K. H., Mulder, C. J. J., Bernstein, C. N., & McCombie, A. M. (2019). Accommodations and adaptations to overcome workplace disability in inflammatory bowel disease patients: A systematic review. Inflammatory Intestinal Diseases, 3(3), 138-144. doi: 10.1159/000495293

King, J. A., Underwood, F. E., Panaccione, N., Quan, J., Windsor, J. W., Kotze, P. G., … Gearry, R., … Kaplan, G. G. (2019). Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: A population-based study of countries in the Organisation for Economic Co-operation and Development. Lancet Gastroenterology & Hepatology, 4(4), 287-295. doi: 10.1016/s2468-1253(19)30013-5

Karim, S., Porter, J. A., McCombie, A., Gearry, R. B., & Day, A. S. (2019). Transition clinics: An observational study of themes important to young people with inflammatory bowel disease. Translational Pediatrics, 8(1), 83-89. doi: 10.21037/tp.2019.01.04

Kortlever, T. L., Ten Bokkel Huinink, S., Offereins, M., Hebblethwaite, C., O'Brien, L., Leeper, J., … Gearry, R. B. (2019). Low-FODMAP diet Is associated with improved quality of life in IBS patients: A prospective observational study. Nutrition in Clinical Practice, 34(4), 623-630. doi: 10.1002/ncp.10233

Paulides, E., Kim, C., Frampton, C., Gearry, R. B., Eglinton, T., Leong, R. W., … McCombie, A. M. (2019). Validation of the inflammatory bowel disease disability index for self-report and development of an item-reduced version. Journal of Gastroenterology & Hepatology, 34, 92-102. doi: 10.1111/jgh.14496

Journal - Research Other

O'Brien, L., Brown, S., Gearry, R. B., & Day, A. S. (2019). Low FODMAP diet-directions for future research. Alimentary Pharmacology & Therapeutics, 49(8), 1107-1108. doi: 10.1111/apt.15175

van Everdingen, C. K., Meijer, B., & Gearry, R. B. (2019). Transient elastography in IBD patients. Inflammatory Bowel Diseases, 25(8), e96. doi: 10.1093/ibd/izz047

Ooi, C. J., Hilmi, I., Banerjee, R., Chuah, S. W., Ng, S. C., Wei, S. C., … Gearry, R., … on behalf of the Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease and Asian Organization for Crohn's and Colitis. (2019). Best practices on immunomodulators and biological agents for ulcerative colitis and Crohn's disease in Asia. Journal of Gastroenterology & Hepatology, 34, 1296-1315. doi: 10.1111/jgh.14648

de Boer, N. K. H., on behalf of the Thiopurine Working Group, including Barclay, M. L., & Gearry, R. B. (2019). Thiopurine therapy in inflammatory bowel diseases: Making new friends should not mean losing old ones. Gastroenterology, 156, 11-19. doi: 10.1053/j.gastro.2018.11.039

Conference Contribution - Published proceedings: Abstract

Vernon-Roberts, A., Frampton, C., Gearry, R., & Day, A. S. (2019). The development and validation of a self-management skills assessment tool for children with inflammatory bowel disease: The IBD-Skills Tasks and Abilities Record (IBD-STAR). Journal of Pediatric Gastroenterology & Nutrition, 69(Suppl. 1), (pp. 137). doi: 10.1097/MPG.0000000000002485

Wallace, A., Eady, S., Butts, C., Hedderley, D., Drummond, L., Ansell, J., & Gearry, R. (2019). The effect of Sungold Kiwifruit (Actinidia Chinensis var. Chinensis) on gut health function: A randomized cross-over clinical trial. Proceedings, 37, 23. doi: 10.3390/proceedings2019037023

Roy, N., Fraser, K., Young, W., Cooney, J., McNabb, W., & Gearry, R. (2019). The COMFORT cohort: Identifying biomarkers relevant to functional gastrointestinal disorders (P20-039-19). Current Developments in Nutrition, 3(Suppl. 1), (pp. 1801). doi: 10.1093/cdn/nzz040.P20-039-19

James, C., Fraser, K., Young, W., McNabb, W., Gearry, R., & Roy, N. (2019). Understanding how metabolites link diet, host, and microbiota in a dysfunctional gut model is important to establishing a system-wide understanding of gut function (P20-035-19). Current Developments in Nutrition, 3(Suppl. 1), (pp. 1797). doi: 10.1093/cdn/nzz040.P20-035-19

Fraser, K., Young, W., McNabb, W., Gearry, R., & Roy, N. (2019). Lipid and metabolite profiles in human plasma and associations with the microbiome and functional gastrointestinal disorders (P20-033-19). Current Developments in Nutrition, 3(Suppl. 1), (pp. 1795). doi: 10.1093/cdn/nzz040.P20-033-19

Young, W., Carco, C., Mullaney, J., Maclean, P., Cotter, P., Fraser, K., … Gearry, R., & Roy, N. (2019). The microbiome in functional gastrointestinal disorders is characterized by bacteria and genes involved in carbohydrate and bile acid metabolism (OR23-01-19). Current Developments in Nutrition, 3(Suppl. 1), (pp. 1749). doi: 10.1093/cdn/nzz040.OR23-01-19

Gearry, R., Frampton, C., Inns, S., Poppelwell, D., Rademaker, M., & Suppiah, R. (2019). VITALITY: Impact of adalimumab (HUMIRA ®) on disability in New Zealand patients with psoriasis, Crohn's disease (CD) or rheumatoid arthritis (RA). Australasian Journal of Dermatology, 60(Suppl. 1), (pp. 82). doi: 10.1111/ajd.13027

Carco, C., Young, W., Mullaney, J. A., Maclean, P., Cotter, P., Fraser, K., … Gearry, R. B., & Roy, N. (2019). The microbiome in irritable bowel syndrome: Insights from a case/control study in New Zealand reveals significant differences in Faecalibacterium, Bilophila, and genes involved in carbohydrate and amino acid metabolism. Gastroenterology, 156(6, Suppl. 1), (pp. S234). doi: 10.1016/S0016-5085(19)37384-6

Falling, C., Stebbings, S., Mani, R., Baxter, D., & Gearry, R. (2019). Central sensitization inventory discriminates between pain groups in individuals with inflammatory bowel disease. Journal of Pain, 20(4, Suppl. 1), (pp. S21). doi: 10.1016/j.jpain.2019.01.103

2018

Journal - Research Article

Wilson, R., Willis, J., Gearry, R. B., Hughes, A., Lawley, B., Skidmore, P., Frampton, C., Fleming, E., Anderson, A., Jones, L., Tannock, G. W., & Carr, A. C. (2018). SunGold kiwifruit supplementation of individuals with prediabetes alters gut microbiota and improves Vitamin C status, anthropometric and clinical markers. Nutrients, 10, 895. doi: 10.3390/nu10070895

Shah, S. C., Khalili, H., Gower-Rousseau, C., Olen, O., Benchimol, E. I., Lynge, E., … Gearry, R., … Colombel, J.-F. (2018). Sex-based differences in incidence of inflammatory bowel diseases: Pooled analysis of population-based studies from Western countries. Gastroenterology, 155(4), 1079-1089. doi: 10.1053/j.gastro.2018.06.043

Roberts, R. L., Wallace, M. C., Seinen, M. L., van Bodegraven, A. A., Krishnaprasad, K., Jones, G. T., van Rij, A. M., … Kennedy, M. A., … Gearry, R. B., … Barclay, M. (2018). Nonsynonymous polymorphism in guanine monophosphate synthetase is a risk factor for unfavorable thiopurine metabolite ratios in patients with inflammatory bowel disease. Inflammatory Bowel Diseases, 24(12), 2606-2612. doi: 10.1093/ibd/izy163

Wright, E. K., Kamm, M. A., De Cruz, P., Hamilton, A. L., Selvaraj, F., Princen, F., … Gearry, R. B., … Connell, W. R. (2018). Anti-TNF therapeutic drug monitoring in postoperative Crohn's disease. Journal of Crohn's & Colitis, 12(6), 653-661. doi: 10.1093/ecco-jcc/jjy003

Lopez, R. N., Evans, H. M., Appleton, L., Bishop, J., Chin, S., Mouat, S., Gearry, R. B., & Day, A. S. (2018). Prospective incidence of paediatric inflammatory bowel disease in New Zealand in 2015: Results from the Paediatric Inflammatory Bowel Disease in New Zealand (PINZ) Study. Journal of Pediatric Gastroenterology & Nutrition, 66(5), e122-e126. doi: 10.1097/mpg.0000000000001806

Meijer, B., van Everdingen, C. K., Ramsoekh, D., Stedman, C., Frampton, C. M. A., Mulder, C. J. J., … Gearry, R. B. (2018). Transient elastography to assess liver stiffness in patients with inflammatory bowel disease. Digestive & Liver Disease, 50(1), 48-53. doi: 10.1016/j.dld.2017.09.128

Asl Baakhtari, S., McCombie, A., Ten Bokkel Huinink, S., Irving, P., Siegel, C. A., Mulder, R., … Gearry, R. (2018). Observational study of perspectives of inflammatory bowel disease patients concerning the use of corticosteroids. Digestive Diseases, 36(1), 33-39. doi: 10.1159/000478772

Lopez, R. N., Appleton, L., Gearry, R. B., & Day, A. S. (2018). Rising incidence of paediatric inflammatory bowel disease in Canterbury, New Zealand, 1996-2015. Journal of Pediatric Gastroenterology & Nutrition, 66(2), e45-e50. doi: 10.1097/mpg.0000000000001688

Bayer, S. B., Gearry, R. B., & Drummond, L. N. (2018). Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function. Critical Reviews in Food Science & Nutrition, 58(14), 2432-2452. doi: 10.1080/10408398.2017.1327841

Siegel, C. A., Whitman, C. B., Spiegel, B. M. R., Feagan, B., Sands, B., Loftus, Jr, E. F., … Gearry, R., … Peyrin-Biroulet, L. (2018). Development of an index to define overall disease severity in IBD. Gut, 67(2), 244-254. doi: 10.1136/gutjnl-2016-312648

Journal - Research Other

Falling, C., Stebbings, S., Baxter, G. D., Gearry, R. B., & Mani, R. (2018). Profile of musculoskeletal pain in patients with inflammatory bowel disease: A study protocol for assessing the multidimensional experience of self-reported pain. Physical Therapy Reviews, 23(3), 227-235. doi: 10.1080/10833196.2018.1500149

Gearry, R. B., & Daker, C. (2018). Ustekinumab and Crohn's disease: What can we learn from long-term extension studies? Alimentary Pharmacology & Therapeutics, 48(3), 382-383. doi: 10.1111/apt.14844

Chen, A. G. Y., Offereins, M. S. L., Mulder, C. J., Frampton, C. M., & Gearry, R. B. (2018). A pilot study of the effect of green kiwifruit on human intestinal fermentation measured by hydrogen and methane breath testing [Short communication]. Journal of Medicinal Food, 21(12), 1295-1298. doi: 10.1089/jmf.2018.4179

Willington, A. J., Taylor, G., White, J., & Gearry, R. B. (2018). Gastrointestinal: Ulcerative colitis-associated duodenitis. Journal of Gastroenterology & Hepatology, 33(5), 973. doi: 10.1111/jgh.13992

Willington, A. J., & Gearry, R. B. (2018). Editorial: Thiopurine-induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype—the perils of ageing. Alimentary Pharmacology & Therapeutics, 47(1), 129-130. doi: 10.1111/apt.14370

Conference Contribution - Published proceedings: Abstract

Young, W., Gearry, R., Cotter, P., Fraser, K., & Roy, N. C. (2018). The microbiome and gastrointestinal comfort: Is there a link? Proceedings, 2(573), (pp. 128-129). doi: 10.3390/proceedings2120573

Fraser, K., Roy, N. C., Stirrat, H., Young, W., & Gearry, R. (2018). Global metabolite profiling of multiple sample types to identify markers for functional gastrointestinal disorders. Proceedings, 2(573), (pp. 41). doi: 10.3390/proceedings2120573

Andrews, A., Wang, C., Wall, C., Gearry, R., Day, A., Tannock, G., & Morgan, X. (2018). Modulation of the gut microbiome in adult Crohn's Disease patients during exclusive enteral nutrition. Proceedings of the New Zealand Microbiological Society (NZMS) New Zealand Society for Biochemistry and Molecular Biology (NZSBMB) Joint Annual Conference: Microbes & Molecules. (pp. 50-51). Retrieved from https://www.nzmsconference.org.nz

Vernon-Roberts, A., Otley, A., Frampton, C., Gearry, R., & Day, A. (2018). IBD-KID2: A revised knowledge assessment tool for children with inflammatory bowel disease. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. Retrieved from http://gastro2018.co.nz

Macintosh, A., Wright-Mcnaughton, M., Gearry, R., Skidmore, P., Frampton, C., Muir, J., & Dwyer, E. (2018). The relationship between FODMAP intake and acute gastrointestinal symptoms in adults with IBS: A novel analysis using the FAST Diary. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. Retrieved from http://gastro2018.co.nz

Vernon-Roberts, A., Lopez, R., Frampton, C., Gearry, R. B., Lemberg, D. A., & Day, A. S. (2018). A symptom self-report tool for children with inflammatory bowel disease. Proceedings of the Paediatric Society of New Zealand 70th Annual Scientific Meeting. (pp. 47). Retrieved from http://www.psnz2018.co.nz

Brown, S., Day, A., Gearry, R., & Whelan, K. (2018). Efficacy of the low FODMAP diet in children and adolescents with functional gastrointestinal disorders. Proceedings of the Paediatric Society of New Zealand 70th Annual Scientific Meeting. (pp. 46). Retrieved from http://www.psnz2018.co.nz

Falling, C., Stebbings, S., Gearry, R., Baxter, G., & Mani, R. (2018). Central sensitization mediates the relationship between inflammatory bowel disease activity and musculoskeletal pain intensity. Proceedings of the International Association for the Study of Pain (IASP) 17th World Congress on Pain. PSN424. Retrieved from https://www.iaspworldcongressonpain.org/

Barbara, R., Fukudo, S., Kuhn-Sherloch, B., Ansell, J., Drummond, L., & Gearry, R. (2018). Green kiwifruit for the relief of constipation and improving digestive comfort in patients with functional constipation and constipation predominant irritable bowel syndrome: Analysis of 3 international trial centres. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. Retrieved from http://gastro2018.co.nz

2017

Journal - Research Article

Wall, C. L., Gearry, R. B., & Day, A. S. (2017). Treatment of active Crohn's disease with exclusive and partial enteral nutrition: A pilot study in adults. Inflammatory Intestinal Diseases, 2(4), 219-227. doi: 10.1159/000489630

Huang, H., Fang, M., Jostins, L., Umićević Mirkov, M., Boucher, G., Anderson, C. A., … International Inflammatory Bowel Disease Genetics Constortium, including Gearry, R., … Barrett, J. C. (2017). Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature, 547, 173-178. doi: 10.1038/nature22969

Rayen, J., Currie, T., Gearry, R. B., Frizelle, F., & Eglinton, T. (2017). The long-term outcome of anti-TNF alpha therapy in perianal Crohn's disease. Techniques in Coloproctology, 21(2), 119-124. doi: 10.1007/s10151-016-1578-4

Blatchford, P., Stoklosinki, H., Eady, S., Wallace, A., Butts, C., Gearry, R., … Ansell, J. (2017). Consumption of kiwifruit capsules increases Faecalibacterium prausnitzii abundance in functionally constipated individuals: A randomised controlled human trial. Journal of Nutritional Science, 6, e52. doi: 10.1017/jns.2017.52

Nanayakkara, W. S., Gearry, R. B., Muir, J. G., O'Brien, L., Wilkinson, T. J., Williman, J. A., & Skidmore, P. M. L. (2017). Gastrointestinal symptoms and FODMAP intake of aged-care residents from Christchurch, New Zealand. Nutrients, 9(10), 1083. doi: 10.3390/nu9101083

Wilson, R., Willis, J., Gearry, R., Skidmore, P., Fleming, E., Frampton, C., & Carr, A. (2017). Inadequate vitamin C status in prediabetes and type 2 diabetes mellitus: Associations with glycaemic control, obesity, and smoking. Nutrients, 9(9), 997. doi: 10.3390/nu9090997

Chen, G.-B., Lee, S. H., Montgomery, G. W., Wray, N. R., Visscher, P. M., Gearry, R. B., … Moser, G. (2017). Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method. BMC Medical Genetics, 18, 94. doi: 10.1186/s12881-017-0451-2

Wallace, A., Eady, S., Drummond, L., Hedderley, D., Ansell, J., & Gearry, R. (2017). A pilot randomized cross-over trial to examine the effect of kiwifruit on satiety and measures of gastric comfort in healthy adult males. Nutrients, 9(7), 639. doi: 10.3390/nu9070639

Lopez, R. N., Evans, H. M., Appleton, L., Bishop, J., Chin, S., Mouat, S., Gearry, R. B., & Day, A. S. (2017). Point prevalence of pediatric inflammatory bowel disease in New Zealand in 2015: Initial results from the PINZ study. Inflammatory Bowel Diseases, 23(8), 1418-1424. doi: 10.1097/mib.0000000000001138

Duvoisin, G., Lopez, R. N., Day, A. S., Lemberg, D. A., Gearry, R. B., & Leach, S. T. (2017). Novel biomarkers and the future potential of biomarkers in inflammatory bowel disease. Mediators of Inflammation, 2017, 1936315. doi: 10.1155/2017/1936315

Julsgaard, M., Hvas, C. L., Gearry, R. B., Vestergaard, T., Fallingborg, J., Svenningsen, L., … Bell, S. J. (2017). Fecal calprotectin is not affected by pregnancy: Clinical implications for the management of pregnant patients with inflammatory bowel disease. Inflammatory Bowel Diseases, 23(7), 1240-1246. doi: 10.1097/mib.0000000000001136

Grant, E., Gearry, R. B., Wilson, R., Pearson, J., & Skidmore, P. M. L. (2017). Home availability of fruit and vegetables and obesogenic foods as an indicator of nutrient intake in 50 year olds from Canterbury, New Zealand. Asia Pacific Journal of Clinical Nutrition, 26(3), 524-530. doi: 10.6133/apjcn.042016.11

Doecke, J. D., Hartnell, F., Bampton, P., Bell, S., Mahy, G., Grover, Z., … Gearry, R. B., … On behalf of Australian and New Zealand Inflammatory Bowel Disease Consortium. (2017). Infliximab vs. adalimumab in Crohn's disease: Results from 327 patients in an Australian and New Zealand observational cohort study. Alimentary Pharmacology & Therapeutics, 45(4), 542-552. doi: 10.1111/apt.13880

Batt, C., Fanning, N., Drake, J., Frampton, C., Gearry, R. B., & Stamp, L. K. (2017). Fructose malabsorption in people with and without gout: A case-control study. Seminars in Arthritis & Rheumatism, 47(2), 257-263. doi: 10.1016/j.semarthrit.2017.03.018

Hamilton, A. L., Kamm, M. A., De Cruz, P., Wright, E. K., Selvaraj, F., Princen, F., … Gearry, R. B., … Connell, W. R. (2017). Serologic antibodies in relation to outcome in postoperative Crohn's disease. Journal of Gastroenterology & Hepatology, 32(6), 1195-1203. doi: 10.1111/jgh.13677

Journal - Research Other

Wall, C. L., Gearry, R. B., & Day, A. S. (2017). New Zealand gastroenterologists’ perceptions, knowledge and experience of exclusive enteral nutrition to treat Crohn’s disease. New Zealand Medical Journal, 130(1464), 77-79. Retrieved from http://www.nzma.org.nz/journal

Lamba, M. J., Tharayil, V. S., & Gearry, R. B. (2017). Does disease extension lead to disease progression in proctitis? Alimentary Pharmacology & Therapeutics, 46(2), 205-206. doi: 10.1111/apt.14129

Lamba, M. J., Tharayil, V. S., & Gearry, R. B. (2017). Inflammatory bowel disease risk reduction after migration: Are early life events important? Alimentary Pharmacology & Therapeutics, 45(10), 1367-1368. doi: 10.1111/apt.14034

Ngu, J. H., Gearry, R. B., & Stedman, C. A. M. (2017). Autoimmune hepatitis in the East and the West. Inflammatory Intestinal Diseases, 1(4), 147-149. doi: 10.1159/000455177

McCombie, A., Gearry, R. B., Lopez, R. N., Lönnfors, S., & Day, A. S. (2017). Enhancements in confidence, acceptance, and friendship at a summer camp for children with inflammatory bowel disease [Short communication]. Journal of Pediatric Gastroenterology & Nutrition, 65(3), 311-313. doi: 10.1097/mpg.0000000000001526

Lee, J. C., Biasci, D., Roberts, R., Gearry, R. B., Mansfield, J. C., Ahmed, T., … Smith, K. G. C. (2017). Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease. Nature Genetics, 49, 262-268. doi: 10.1038/ng.3755

Lopez, R. N., Leach, S. T., Lemberg, D. A., Duvoisin, G., Gearry, R. B., & Day, A. S. (2017). Fecal biomarkers in inflammatory bowel disease. Journal of Gastroenterology & Hepatology, 32(3), 577-582. doi: 10.1111/jgh.13611

Conference Contribution - Published proceedings: Abstract

Tharayil, V., Taylor, K., & Gearry, R. (2017). Performance of novel mycobacterial detection test in Crohn's disease: Preliminary results from OPTIONS study. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 70. Retrieved from http://gastro2017.co.nz

Willington, A., Taylor, G., White, J., & Gearry, R. (2017). Ulcerative colitis-associated duodenitis. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 76. Retrieved from http://gastro2017.co.nz

Willington, A., Heenan, P., Sharma, S., & Gearry, R. (2017). Impact of IBS on patients' self-reported quality of life: Preliminary results from the Christchurch IBS cOhort to investigate Mechanisms FOr gut Relief and improved Transit (COMFORT) study. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 75. Retrieved from http://gastro2017.co.nz

Sharma, S., Heenan, P., Keenan, J., Willington, A., & Gearry, R. (2017). The association between smoking and belly pain in participants from the Christchurch IBS cOhort to investigate Mechanisms FOr gut Relief and improved Transit (COMFORT). Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 67. Retrieved from http://gastro2017.co.nz

Paulides, E., Kim, C., Eglinton, T., Gearry, R. B., Mulder, C., Frampton, C., … McCombie, A. M. (2017). Validation of the Inflammatory Bowel Disease Disability Index for self-report. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 58. Retrieved from http://gastro2017.co.nz

Lamba, M., Burt, M., Alamri, Y., Falvey, J., & Gearry, R. (2017). Predictors of non-attendance at outpatient endoscopy appointments: Five year Canterbury study. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 37. Retrieved from http://gastro2017.co.nz

Heenan, P., Sharma, S., Keenan, J., Willington, A., & Gearry, R. (2017). Anxiety and depression are associated with irritable bowel syndrome: Preliminary results from Christchurch IBS cOhort to investigate Mechanisms FOr gut Relief and improved Transit (COMFORT) study. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 22. Retrieved from http://gastro2017.co.nz

Chen, A., McCombie, A., Fletcher, J., Gearry, R., Ho, C., Mackay, M., … Inns, S. (2017). Inflammatory bowel disease nurse services in New Zealand. Proceedings of the New Zealand Society of Gastroenterology and the NZNO Gastroenterology Nurses' College Annual Scientific Meeting. 5. Retrieved from http://gastro2017.co.nz

Wu, Y., Ghaly, S., Kerr, S., Krishnaprasad, K., Prosser, R., Jackson, B., … Gearry, R., … Lawrance, I. C. (2017). UV exposure and skin type are more important than thiopurine exposure for non-melanoma skin cancer risk in IBD. Journal of Crohn's & Colitis, 11(Suppl. 1), (pp. S433-S434). doi: 10.1093/ecco-jcc/jjx002.815

Roy, N., Fraser, K., Noh, H., Young, W., & Gearry, R. (2017). Global metabolite profiling of multiple sample types to identify markers for Irritable Bowel Syndrome (IBS). Neurogastroenterology & Motility, 29(Suppl. 2), (pp. 53). doi: 10.1111/nmo.13180

Wallace, A., Eady, S., Drummond, D., Hedderley, D., Ansell, J., & Gearry, R. (2017). A randomised cross over trial to examine the effect of kiwifruit on protein digestion in healthy adult males. Nutrients, 9(4). doi: 10.3390/nu9040348

Cremon, C., Pagano, I., Marcellini, M. M., Barbaro, M. R., Gearry, R., Fukudo, S., … Barbaro, G. (2017). The effect of Zespri green kiwifruit on digestive and gut health functions. Neurogastroenterology & Motility, 29(Suppl. 1), (pp. 29-30). [Abstract]

Batt, C., Fanning, N., Drake, J., Frampton, C., Gearry, R., & Stamp, L. (2017). Fructose malabsorption in people with gout and effect of allopurinol: Implications for diet. Internal Medicine Journal, 47(Suppl. 2), (pp. 8). doi: 10.1111/imj.13426

Wall, C., Gearry, R., & Day, A. (2017). Enteral nutrition in the treatment of young adults with active Crohn's disease. Journal of Crohn's & Colitis, 11(Suppl. 1), P635, (pp. S404-S405). doi: 10.1093/ecco-jcc/jjx002.759

Conference Contribution - Poster Presentation (not in published proceedings)

Lawley, B., Wall, C., Day, A. S., Gearry, R. B., Young, W., & Tannock, G. W. (2017, September). Urinary metabolome analysis of Crohn’s disease (CD) patients and healthy controls (HC) undertaking short-term exclusive enteral nutrition (EEN). Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Nanayakkara, W. S., Gearry, R. B., Muir, J. G., O'Brien, L., Wilkinson, T. J., Williman, J. A., & Skidmore, P. M. L. (2017, August-September). Gastrointestinal symptoms and FODMAP intake of aged-care residents from Christchurch, New Zealand. Verbal presentation at the Dietitians NZ National Professional Development Meeting, Wellington, New Zealand.

Wilson, R., Willis, J., Gearry, R., Skidmore, P., Tannock, G., Lawley, B., Fleming, L., & Frampton, C. (2017, May). Characterisation of the gut microbiota in individuals across the glycaemic spectrum: A pilot study. Verbal presentation at the New Zealand Society for the Study of Diabetes (NZSSD) Annual Scientific Meeting, Dunedin, New Zealand.

Stedman, C., Gearry, R., & Lim, G. (2017, August). Gastroenterology: Basics and beyond. Workshop presentation at the 8th South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.

2016

Journal - Research Article

Feagan, B. G., Sandborn, W. J., Gasink, C., Jacobstein, D., Lang, Y., Friedman, J. R., … for the UNITI—IM–UNITI Study Group, including Gearry, R. (2016). Ustekinumab as induction and maintenance therapy for Crohn's disease. New England Journal of Medicine, 375, 1946-1960. doi: 10.1056/NEJMoa1602773

Sandborn, W. J., Feagan, B. G., Wolf, D. C., D'Haens, G., Vermeire, S., Hanauer, S. B., … for the TOUCHSTONE Study Group, including Gearry, R. B. (2016). Ozanimod induction and maintenance treatment for ulcerative colitis. New England Journal of Medicine, 374, 1754-1762. doi: 10.1056/NEJMoa1513248

Regueiro, M., Feagan, B. G., Zou, B., Johanns, J., Blank, M. A., Chevrier, M., … for the PREVENT Study Group, including Gearry, R. B. (2016). Infliximab reduces endoscopic, but not clinical, recurrence of Crohn's disease after ileocolonic resection. Gastroenterology, 150, 1568-1578. doi: 10.1053/j.gastro.2016.02.072

Su, H. Y., Gupta, V., Day, A. S., & Gearry, R. B. (2016). Rising incidence of inflammatory bowel disease in Canterbury, New Zealand. Inflammatory Bowel Diseases, 22(9), 2238-2244. doi: 10.1097/mib.0000000000000829

McCombie, A., Lee, Y., Vanamala, R., Gearry, R., Frizelle, F., Mckay, E., Williman, J., & Eglinton, T. (2016). Early postoperative complications have long-term impact on quality of life after restorative proctocolectomy. Medicine, 95(27), e3966. doi: 10.1097/md.0000000000003966

Nanayakkara, W. S., Skidmore, P. M. L., O'Brien, L., Wilkinson, T. J., & Gearry, R. B. (2016). Efficacy of the low FODMAP diet for treating irritable bowel syndrome: The evidence to date. Clinical & Experimental Gastroenterology, 9, 131-142. doi: 10.2147/CEG.S86798

Lee, Y., McCombie, A., Gearry, R., Frizelle, F. A., Vanamala, R., Leong, R. W., & Eglinton, T. (2016). Disability in restorative proctocolectomy recipients measured using the inflammatory bowel disease disability index. Journal of Crohn's & Colitis, 10(12), 1378-1384. doi: 10.1093/ecco-jcc/jjw114

Julsgaard, M., Christensen, L. A., Gibson, P. R., Gearry, R. B., Fallingborg, J., Hvas, C. L., … Bell, S. J. (2016). Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection. Gastroenterology, 151(1), 110-119. doi: 10.1053/j.gastro.2016.04.002

Gearry, R. B. (2016). IBD and environment: Are there differences between East and West. Digestive Diseases, 34(1-2), 84-89. doi: 10.1159/000442933

De Voogd, F. A. E., Gearry, R. B., Mulder, C. J., & Day, A. S. (2016). Osteoprotegerin: A novel biomarker for inflammatory bowel disease and gastrointestinal carcinoma. Journal of Gastroenterology & Hepatology, 31, 1386-1392. doi: 10.1111/jgh.13324

McCombie, A., Swaminathan, A., Mulder, R., Frampton, C., Kortlever, T., & Gearry, R. (2016). The IBD-Cope: A new instrument for measuring coping in inflammatory bowel disease patients. Journal of Crohn's & Colitis, 10(6), 678-686. doi: 10.1093/ecco-jcc/jjw028

Wright, E. K., Kamm, M. A., De Cruz, P., Hamilton, A. L., Ritchie, K. J., Keenan, J. I., … Burgess, L., Aitchison, A., … Day, A. S., & Gearry, R. B. (2016). Comparison of fecal inflammatory markers in Crohn's disease. Inflammatory Bowel Diseases, 22(5), 1086-1094. doi: 10.1097/mib.0000000000000671

Cleynen, I., Boucher, G., Jostins, L., Schumm, L. P., Zeissig, S., Ahmad, T., … Gearry, R. B., … Lees, C. W. (2016). Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: A genetic association study. Lancet, 387(10014), 9-15. doi: 10.1016/s0140-6736(15)00465-1

McCombie, A., Gearry, R., Andrews, J., Mulder, R., & Mikocka-Walus, A. (2016). Does computerized cognitive behavioral therapy help people with inflammatory bowel disease? A randomized controlled trial. Inflammatory Bowel Diseases, 22(1), 171-181. doi: 10.1097/mib.0000000000000567

Journal - Research Other

Kortlever, T., Hebblethwaite, C., Leeper, J., O'Brien, L., Mulder, C., & Gearry, R. B. (2016). Low FODMAP diet efficacy in IBS patients: What is the evidence and what else do we need to know? New Zealand Medical Journal, 129(1442), 79-87. Retrieved from https://www.nzma.org.nz/journal

Fulforth, J. M., & Gearry, R. B. (2016). Inflammatory bowel disease risk and the environment: Where to next? Journal of Gastroenterology & Hepatology, 31(6), 1074-1075. doi: 10.1111/jgh.13375

Journal - Professional & Other Non-Research Articles

Bernstein, C. N., Eliakim, A., Fedail, S., Fried, M., Gearry, R., Goh, K.-L., … LeMair, A. (2016). World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: Update August 2015. Journal of Clinical Gastroenterology, 50(10), 803-818. doi: 10.1097/MCG.0000000000000660

Ooi, C. J., Makharia, G. K., Hilmi, I., Gibson, P. R., Fock, K. M., Ahuja, V., … Gearry, R. B., … on behalf of the Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease. (2016). Asia–Pacific consensus statements on Crohn's disease. Part 2: Management. Journal of Gastroenterology & Hepatology, 31(1), 56-68. doi: 10.1111/jgh.12958

Ooi, C. J., Makharia, G. K., Hilmi, I., Gibson, P. R., Fock, K. M., Ahuja, V., … Gearry, R. B., … on behalf of the Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease. (2016). Asia Pacific consensus statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology. Journal of Gastroenterology & Hepatology, 31(1), 45-55. doi: 10.1111/jgh.12956

Conference Contribution - Published proceedings: Full paper

Gearry, R. B. (2016). Biosimilar and innovator anti-Tumour Necrosis Factor (TNF) or lymphocyte trafficking blockade: Which one to select? Journal of Gastroenterology & Hepatology, 31(Suppl. 1), (pp. 24-25). doi: 10.1111/jgh.13357

Gearry, R. B. (2016). Treat to target: What is realistic in Australian practice today? Journal of Gastroenterology & Hepatology, 31(Suppl. 1), (pp. 4-5). doi: 10.1111/jgh.13344

Conference Contribution - Published proceedings: Abstract

Ngu, J. H., Koay, D. S., Salazar, E., Gearry, R. B., & Stedman, C. A. (2016). Phenotypes of autoimmune hepatitis (AIH) in the West and the East: Comparison of AIH patients in Christchurch and Singapore. Gastroenterology, 150(4, Suppl. 1), (pp. S1075). doi: 10.1016/S0016-5085(16)33625-3

De Voogd, F., Burgess, L., Gearry, R., & Day, A. S. (2016). Faecal osteoprotegerin correlates with disease activity and predicts disease relapse in paediatric inflammatory bowel disease. Journal of Crohn's & Colitis, 10(Suppl. 1), (pp. S175). doi: 10.1093/ecco-jcc/jjw019.289

Wall, C. L., Gearry, R. B., & Day, A. S. (2016). Enteral nutrition in the treatment of active Crohn's disease. Proceedings of the Dietitians New Zealand National Meeting: Nourishing Our Knowledge. (pp. 27-28). Retrieved from http://dietitians.org.nz/

Gearry, R. B. (2016). Introduction. Journal of Gastroenterology & Hepatology, 31(Suppl. 1), (pp. 23). doi: 10.1111/jgh.13356

Conference Contribution - Poster Presentation (not in published proceedings)

Chen, A., Offereins, M., Mulder, C., Frampton, C., & Gearry, R. (2016, November). Kiwifruit and digestive comfort: The effect of green kiwifruit on intestinal fermentation in humans measured by hydrogen and methane breath testing. Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation (NZNO) Gastroenterology Nurses Section Annual Scientific Meeting, Hamilton, New Zealand.

Wall, C. L., Gearry, R. B., & Day, A. S. (2016, November). Exclusive enteral nutrition in the treatment of Crohn's disease: New Zealand gastroenterologists' perspectives. Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation (NZNO) Gastroenterology Nurses Section Annual Scientific Meeting, Hamilton, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Gearry, R. (2016, September). A gastroenterologist view of the role of surgery in Crohn's disease. Verbal presentation at the Colorectal Surgical Society of Australia and New Zealand (CSSANZ) and the Colon & Rectal Surgery Section, Royal Australasian College of Surgeons (RACS) Spring Colorectal Meeting, Queenstown, New Zealand.

McCombie, A., Gearry, R., & Eglinton, T. (2016, November). Helping ulcerative colitis patients to make important decisions about surgery. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation (NZNO) Gastroenterology Nurses Section Annual Scientific Meeting, Hamilton, New Zealand.

Wall, C. L., Gearry, R. B., & Day, A. S. (2016, November). Enteral nutrition in the treatment of active Crohn's disease. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation (NZNO) Gastroenterology Nurses Section Annual Scientific Meeting, Hamilton, New Zealand.

Gearry, R. B., Barbara, G., Fukudo, S., Ansell, J., Eady, S., Wallace, A., … Drummond, L. (2016, November). The effect of Zespri Green Kiwifruit on digestive and gut health function: A controlled randomised cross-over intervention study. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation (NZNO) Gastroenterology Nurses Section Annual Scientific Meeting, Hamilton, New Zealand.

Kortlever, T., Ten Bokkel Huinink, S., Offereins, M., Hebblethwaite, C., Leeper, J. A., O'Brien, L. A., … Gearry, R. B. (2016, November). The effect of low FODMAP diet on long term global health outcomes in IBS patients. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation (NZNO) Gastroenterology Nurses Section Annual Scientific Meeting, Hamilton, New Zealand.

Wall, C. L., Gearry, R. B., & Day, A. S. (2016, November). Faecal biomarkers of active Crohn's disease. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation (NZNO) Gastroenterology Nurses Section Annual Scientific Meeting, Hamilton, New Zealand.

Chapman, B. A., Cornelius, D. J., Dobbs, B. R., & Gearry, R. B. (2016, November). Audit of prior investigations in 50 cases with capsule findings consistent with Crohn's disease in Christchurch. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation (NZNO) Gastroenterology Nurses Section Annual Scientific Meeting, Hamilton, New Zealand.

Gearry, R. (2016, August). A revolution in reflux: Tackling the therapeutic gap. Workshop presentation at the South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.

2015

Journal - Research Article

Heap, G. A., So, K., Weedon, M., Edney, N., Bewshea, C., Singh, A., … Gearry, R., … Ahmad, T. (2015). Clinical features and HLA association of 5-aminosalicylate (5-ASA)-induced nephrotoxicity in inflammatory bowel disease. Journal of Crohn's & Colitis, 10(2), 149-158. doi: 10.1093/ecco-jcc/jjv219

Boon, G. J. A. M., Day, A. S., Mulder, C. J., & Gearry, R. B. (2015). Are faecal markers good indicators of mucosal healing in inflammatory bowel disease? World Journal of Gastroenterology, 21(40), 11469-11480. doi: 10.3748/wjg.v21.i40.11469

Peyrin-Biroulet, L., Sandborn, W., Sands, B. E., Reinisch, W., Bemelman, W., Bryant, R. V., … Gearry, R., … Colombel, J.-F. (2015). Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining therapeutic goals for treat-to-target. American Journal of Gastroenterology, 110, 1324-1338. doi: 10.1038/ajg.2015.233

Blatchford, P., Stoklosinski, H., Walton, G., Swann, J., Gibson, G., Gearry, R., & Ansell, J. (2015). Kiwifruit fermentation drives positive gut microbial and metabolic changes irrespective of initial microbiota composition. Bioactive Carbohydrates & Dietary Fibre, 6(1), 37-45. doi: 10.1016/j.bcdf.2015.07.001

McCombie, A. M., Mulder, R. T., & Gearry, R. B. (2015). Coping strategies and psychological outcomes of patients with inflammatory bowel disease in the first 6 months after diagnosis. Inflammatory Bowel Diseases, 21, 2272-2280. doi: 10.1097/mib.0000000000000476

Magon, N. J., Turner, R., Gearry, R. B., Hampton, M. B., Sly, P. D., & Kettle, A. J. (2015). Oxidation of calprotectin by hypochlorous acid prevents chelation of essential metal ions and allows bacterial growth: Relevance to infections in cystic fibrosis. Free Radical Biology & Medicine, 86, 133-144. doi: 10.1016/j.freeradbiomed.2015.05.022

Ansell, J., Butts, C. A., Paturi, G., Eady, S. L., Wallace, A. J., Hedderley, D., & Gearry, R. B. (2015). Kiwifruit-derived supplements increase stool frequency in healthy adults: A randomized, double-blind, placebo-controlled study. Nutrition Research, 35, 401-408. doi: 10.1016/j.nutres.2015.04.005

Wright, E. K., Kamm, M. A., De Cruz, P., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., … Gearry, R. B., … Desmond, P. V. (2015). Effect of intestinal resection on quality of life in Crohn's disease. Journal of Crohn's & Colitis, 9(6), 452-462. doi: 10.1093/ecco-jcc/jjv058

Ko, Y., Kariyawasam, V., Karnib, M., Butcher, R., Samuels, D., Alrubaie, A., … Gearry, R., … on behalf of the IBD Sydney Organisation. (2015). Inflammatory bowel disease environmental risk factors: A population-based case-control study of Middle Eastern migration to Australia. Clinical Gastroenterology & Hepatology, 13, 1453-1463. doi: 10.1016/j.cgh.2015.02.045

Falvey, J. D., Hoskin, T., Meijer, B., Ashcroft, A., Walmsley, R., Day, A. S., & Gearry, R. B. (2015). Disease activity assessment in IBD: Clinical indices and biomarkers fail to predict endoscopic remission. Inflammatory Bowel Diseases, 21, 824-831. doi: 10.1097/mib.0000000000000341

McCombie, A., Gearry, R., Andrews, J., Mikocka-Walus, A., & Mulder, R. (2015). Computerised cognitive behavioural therapy for psychological distress in patients with physical illnesses: A systematic review. Journal of Clinical Psychology in Medical Settings, 22(1), 20-44. doi: 10.1007/s10880-015-9420-0

Wright, E. K., Kamm, M. A., De Cruz, P., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., … Day, A. S., … Gearry, R. B. (2015). Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease following surgery. Gastroenterology, 148, 938-947. doi: 10.1053/j.gastro.2015.01.026

De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., Gorelik, A., … Gearry, R. B., … Desmond, P. V. (2015). Crohn's disease management after intestinal resection: A randomised trial. Lancet, 385(9976), 1406-1417. doi: 10.1016/s0140-6736(14)61908-5

Doecke, J. D., Simms, L. A., Zhao, Z. Z., Roberts, R. L., Fowler, E. V., Croft, A., … Barclay, M. L., Merriman, T. R., Gearry, R. B., … Radford-Smith, G. L. (2015). Smoking behaviour modifies IL23r-associated disease risk in patients with Crohn's disease. Journal of Gastroenterology & Hepatology, 30(2), 299-307. doi: 10.1111/jgh.12674

Journal - Professional & Other Non-Research Articles

Eliadou, E., Day, A. S., Thompson-Fawcett, M., Gearry, R. B., Rowbotham, D. S., Walmsley, R., Schultz, M., Inns, S. J., on behalf of IBDNZ. (2015). New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis. New Zealand Medical Journal, 128(1423), 63-76. Retrieved from http://www.nzma.org.nz/journal

Conference Contribution - Published proceedings: Abstract

Day, A. S., Peters van Ton, A. M., Burgess, L., & Gearry, R. B. (2015). The role of faecal S100A12 in monitoring disease activity and predicting relapses in paediatric inflammatory bowel disease. Gastroenterology, 148(4,), Suppl. 1, (pp. S250). doi: 10.1016/S0016-5085(15)30824-6

Gearry, R. (2015). Nutrition and gut inflammation: Lessons from inflammatory bowel disease [Plenary]. Proceedings of the Nutrition Society of Australia, 39, (pp. 37). Sydney, Australia: Nutrition Society of Australia. [Abstract]

Conference Contribution - Verbal presentation and other Conference outputs

Lee, Y., McCombie, A., Gearry, R., Frizelle, F., Williman, J., Leong, R. W., & Eglinton, T. (2015, November). The inflammatory bowel disease disability index applied to ileal pouch anal anastomoses in New Zealand. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Section Annual Scientific Meeting, Rotorua, New Zealand.

2014

Journal - Research Article

Wilson, R., Gearry, R. B., Grant, E., Pearson, J., & Skidmore, P. M. L. (2014). Home food availability is associated with multiple socio-economic indicators in 50 year olds from Canterbury, New Zealand. Asia Pacific Journal of Clinical Nutrition, 23(4), 714-722. doi: 10.6133/apjcn.2014.23.4.04

Spencer, R., Gearry, R., Pearson, J., & Skidmore, P. (2014). Relationship between fructose and lactose intakes and functional gastrointestinal symptoms in a sample of 50-year-old Cantabrians in New Zealand. New Zealand Medical Journal, 127(1406). Retrieved from http://www.nzma.org.nz/journal

Ungaro, R., Bernstein, C. N., Gearry, R., Hviid, A., Kolho, K.-L., Kronman, M. P., … Atreja, A. (2014). Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: A meta-analysis. American Journal of Gastroenterology, 109, 1728-1738. doi: 10.1038/ajg.2014.246

Wall, C. L., Gearry, R. B., & Day, A. S. (2014). Polymeric formula is more palatable than elemental formula to adults with Crohn’s disease. e-SPEN Journal, 9(6), e200-e203. doi: 10.1016/j.clnme.2014.08.003

Wall, C. L., Gearry, R. B., Pearson, J., Parnell, W., & Skidmore, P. M. L. (2014). Dietary intake in midlife and associations with standard of living, education and nutrition literacy. New Zealand Medical Journal, 127(1397). Retrieved from http://www.nzma.org.nz/journal

Thomas, G. R., Lewis-Morris, T., Rowbotham, D., Whiteside, C., Joyce, S., Inns, S., Schultz, M., & Gearry, R. B. (2014). Adalimumab for Crohn’s disease in New Zealand: A prospective multicentre experience. New Zealand Medical Journal, 127(1396). Retrieved from http://www.nzma.org.nz/journal

Wright, E. K., Williams, J., Andrews, J. M., Day, A. S., Gearry, R. B., Bampton, P., … De Cruz, P. (2014). Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel disease. Internal Medicine Journal, 44(5), 490-496. doi: 10.1111/imj.12402

Day, A. S., Lemberg, D. A., & Gearry, R. B. (2014). Inflammatory bowel disease in Australasian children and adolescents. Gastroenterology Research & Practice, 2014, 703890. doi: 10.1155/2014/703890

McCombie, A., Gearry, R., & Mulder, R. (2014). Preferences of inflammatory bowel disease patients for computerised versus face-to-face psychological interventions. Journal of Crohn's & Colitis, 8(6), 536-542. doi: 10.1016/j.crohns.2013.11.011

Meijer, B., Hoskin, T., Ashcroft, A., Burgess, L., Keenan, J. I., Falvey, J., Gearry, R. B., & Day, A. S. (2014). Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD. Journal of Crohn's & Colitis, 8(6), 513-520. doi: 10.1016/j.crohns.2013.11.004

Conference Contribution - Published proceedings: Abstract

Nolan, A., Roberts, R. L., Wallace, M. C., Pearson, J., van Rij, A., Jones, G. T., Jackson, P. M., Schultz, M. P., Day, A. S., & Gearry, R. B. (2014). Genetic association of oral Crohn disease with intestinal Crohn disease. Oral Surgery, Oral Medicine, Oral Pathology & Oral Radiology, 117(5), (pp. e347). doi: 10.1016/j.oooo.2014.01.072

Wright, E. K., De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, S., … Day, A. S., Gearry, R. B., … Desmond, P. V. (2014). Intestinal resection in Crohn's disease is associated with significant and durable improvement in health related quality of life although to a lesser extent in women and smokers: Results from the POCER Study. Gastroenterology, 146(5, Suppl. 1), (pp. S-435). doi: 10.1016/S0016-5085(14)61564-X

Wright, E. K., De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, S., … Keenan, J. I., … Day, A. S., Gearry, R. B., & Desmond, P. V. (2014). Faecal calprotectin is superior to faecal lactoferrin and S100A12 as a surrogate marker for post-operative Crohn's disease endoscopic recurrence: Prospective longitudinal endoscopic validation: Results from the POCER Study. Gastroenterology, 146(5, Suppl. 1), (pp. S-174). doi: 10.1016/S0016-5085(14)60617-X

Conference Contribution - Poster Presentation (not in published proceedings)

Wall, C. L., Gearry, R. B., & Day, A. S. (2014, November). Exclusive enteral nutrition is a treatment option for selected adults with active Crohn's disease. Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.

McCombie, A., Swaminathan, A., Mulder, R., & Gearry, R. (2014, November). The IBD-Cope: A new instrument for measuring coping in inflammatory bowel disease patients. Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.

Asl Baakhtari, S., McCombie, A., Mulder, R., Falvey, J., Siegel, C. A., Irving, P. M., … Gearry, R. B. (2014, November). Efficacy, toxicity and positive psychological effects drive IBD patient preferences on steroid use. Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.

Peters van Ton, A. M., Burgess, L., Gearry, R. B., & Day, A. S. (2014, November). The role of faecal S100A12 in monitoring disease activity and predicting relapses in paediatric inflammatory bowel disease. Poster session presented at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

McCombie, A. M., Mulder, R. T., & Gearry, R. B. (2014, November). Does computerised cognitive behavioural therapy help people with inflammatory bowel disease? A randomized controlled trial. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.

Wall, C. L., Tannock, G. W., Lawley, B., Otal, A., Gearry, R. B., & Day, A. S. (2014, November). Exclusive enteral nutrition and reintroduction of solid food affect faecal microbiota composition: Results of a pilot study. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Auckland, New Zealand.

Gearry, R. (2014, July). The fire inside: Inflammatory bowel disease. Verbal presentation at the Oxygen Theme Meeting, Christchurch, New Zealand.

2013

Chapter in Book - Research

Drummond, L., & Gearry, R. B. (2013). Kiwifruit modulation of gastrointestinal motility. In M. Boland & P. J. Moughan (Eds.), Advances in food and nutrition research (Vol. 68): Nutritional benefits of kiwifruit. (pp. 219-232). Waltham, MA: Academic Press. doi: 10.1016/B978-0-12-394294-4.00012-2

Journal - Research Article

International Multiple Sclerosis Genetic Consortium (IMSGC), and also Mason, D., Barclay, M., Roberts, R., & Gearry, R. (2013). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature Genetics, 45(11), 1353-1360. doi: 10.1038/ng.2770

Beaudoin, M., Goyette, P., Boucher, G., Lo, K. S., Rivas, M. A., Stevens, C., … and also Barclay, M., Gearry, R., & Roberts, R. (2013). Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis. PLoS Genetics, 9(9), e1003723. doi: 10.1371/journal.pgen.1003723

Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., … for the GEMINI 2 Study Group, including Gearry, R., Schultz, M., & Wyeth, J. (2013). Vedolizumab as induction and maintenance therapy for Crohn's disease. New England Journal of Medicine, 369(8), 711-721. doi: 10.1056/NEJMoa1215739

Wall, C. L., Day, A. S., & Gearry, R. B. (2013). Use of exclusive enteral nutrition in adults with Crohn's disease: A review. World Journal of Gastroenterology, 19(43), 7652-7660. doi: 10.3748/wjg.v19.i43.7652

Day, A. S., Ehn, M., Gearry, R. B., Lemberg, D. A., & Leach, S. T. (2013). Fecal S100A12 in healthy infants and children. Disease Markers, 35(5), 295-299. doi: 10.1155/2013/873582

Falvey, J. D., Bentley, R. W., Merriman, T. R., Hampton, M. B., Barclay, M. L., Gearry, R. B., & Roberts, R. L. (2013). Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: An association study in New Zealand Caucasians and meta-analysis. World Journal of Gastroenterology, 19(39), 6656-6664. doi: 10.3748/wjg.v19.i39.6656

Ngu, J. H., Gearry, R. B., Frampton, C. M., & Stedman, C. A. M. (2013). Autoimmune hepatitis: The role of environmental risk factors: A population-based study. Hepatology International, 7(3), 869-875. doi: 10.1007/s12072-013-9448-x

Lee, J. C., Espéli, M., Anderson, C. A., Linterman, M. A., Pocock, J. M., Williams, N. J., Roberts, R., … Gearry, R., … Smith, K. G. C. (2013). Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway. Cell, 155(1), 57-69. doi: 10.1016/j.cell.2013.08.034

Ngu, J. H., Wallace, M. C., Merriman, T. R., Gearry, R. B., Stedman, C. A. M., & Roberts, R. L. (2013). Association of the HLA locus and TNF with type I autoimmune hepatitis susceptibility in New Zealand Caucasians. SpringerPlus, 2(1), 355. doi: 10.1186/2193-1801-2-355

Nasir, B. F., Griffiths, L. R., Nasir, A., Roberts, R., Barclay, M., Gearry, R. B., & Lea, R. A. (2013). An envirogenomic signature is associated with risk of IBD-related surgery in a population-based Crohn’s disease cohort. Journal of Gastrointestinal Surgery, 17(9), 1643-1650. doi: 10.1007/s11605-013-2250-1

Lawrance, I. C., Murray, K., Batman, B., Gearry, R. B., Grafton, R., Krishnaprasad, K., … Hanigan, K. (2013). Crohn's disease and smoking: Is it ever too late to quit? Journal of Crohn's & Colitis, 7(12), e665-e671. doi: 10.1016/j.crohns.2013.05.007

Schluter, P. J., Spittlehouse, J. K., Cameron, V. A., Chambers, S., Gearry, R., Jamieson, H. A., Kennedy, M., Lacey, C. J., Murdoch, D. R., Pearson, J., Porter, R. J., Richards, M., Skidmore, P. M. L., Troughton, R., Vierck, E., & Joyce, P. R. (2013). Canterbury Health, Ageing and Life Course (CHALICE) study: Rationale, design and methodology. New Zealand Medical Journal, 126(1375). Retrieved from http://www.nzma.org.nz/journal

de Roest, R. H., Dobbs, B. R., Chapman, B. A., Batman, B., O'Brien, L. A., Leeper, J. A., … Gearry, R. B. (2013). The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: A prospective study. International Journal of Clinical Practice, 67(9), 895-903. doi: 10.1111/ijcp.12128

Ngu, J. H., Gearry, R. B., Frampton, C. M., & Stedman, C. A. M. (2013). Predictors of poor outcome in patients with autoimmune hepatitis: A population-based study. Hepatology, 57(6), 2399-2406. doi: 10.1002/hep.26290

Keenan, J. I., Salm, N., Pearson, J. F., Gearry, R. B., & Day, A. S. (2013). Campylobacter seroreactivity in adults with recent onset of Crohn’s disease. Journal of Gastroenterology & Hepatology Research, 2(3), 468-472. doi: 10.6051/j.issn.2224-3992.2013.02.228

McCombie, A. M., Mulder, R. T., & Gearry, R. B. (2013). Psychotherapy for inflammatory bowel disease: A review and update. Journal of Crohn's & Colitis, 7(12), 935-949. doi: 10.1016/j.crohns.2013.02.004

Koning, M., Ailabouni, R., Gearry, R. B., Frampton, C. M. A., & Barclay, M. L. (2013). Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: A population-based, case-control study. Inflammatory Bowel Diseases, 19(4), 767-778. doi: 10.1097/MIB.0b013e31827f27c8

Doecke, J. D., Simms, L. A., Zhao, Z. Z., Huang, N., Hanigan, K., Krishnaprasad, K., Roberts, R. L., … Gearry, R. B., … Radford-Smith, G. L. (2013). Genetic susceptibility in IBD: Overlap between ulcerative colitis and Crohn's disease. Inflammatory Bowel Diseases, 19(2), 240-245. doi: 10.1097/MIB.0b013e3182810041

Gearry, R. B., Kamm, M. A., Hart, A. L., Bassett, P., Gabe, S. M., & Nightingale, J. M. (2013). Predictors for developing intestinal failure in patients with Crohn's disease. Journal of Gastroenterology & Hepatology, 28(5), 801-807. doi: 10.1111/jgh.12115

McCombie, A. M., Mulder, R. T., & Gearry, R. B. (2013). How IBD patients cope with IBD: A systematic review. Journal of Crohn's & Colitis, 7(2), 89-106. doi: 10.1016/j.crohns.2012.05.021

Nasir, B. F., Griffiths, L., Nasir, A., Roberts, R., Barclay, M., Gearry, R., & Lea, R. A. (2013). Perianal disease combined with NOD2 genotype predicts need for IBD-related surgery in Crohn's disease patients from a population-based cohort. Journal of Clinical Gastroenterology, 47(3), 242-245. doi: 10.1097/MCG.0b013e318258314d

Journal - Research Other

Gearry, R. B., & Leong, R. W. (2013). Inflammatory bowel disease in Asia: The start of the epidemic? Journal of Gastroenterology & Hepatology, 28(6), 899-900. doi: 10.1111/jgh.12218

Falvey, J. D., Gearry, R. B., & Day, A. S. (2013). Fecal calprotectin does not predict endoscopic remission in inflammatory bowel disease. Inflammatory Bowel Diseases, 19(6), E80-E81. doi: 10.1097/MIB.0b013e31828dc6d3

Sutharshan, K., & Gearry, R. B. (2013). Temporary adalimumab dose escalation is effective in Crohn's disease patients with secondary non-response. Journal of Crohn's & Colitis, 7(7), e277-e278. doi: 10.1016/j.crohns.2013.01.002

Journal - Professional & Other Non-Research Articles

Ngu, J. H., Gearry, R. B., & Stedman, C. A. M. (2013). Mortality and the risk of malignancy in autoimmune liver diseases: A population-based study in Canterbury, New Zealand: Reply. Hepatology, 57(4), 1677-1678. doi: 10.1002/hep.25968

Conference Contribution - Published proceedings: Abstract

Skidmore, P. M. L., Grant, E., Gearry, R. B., Wilson, R., & Pearson, J. (2013). Home availability of fruit and vegetables and obesogenic foods as an indicator of nutrient intake in 50 year olds from Canterbury, New Zealand. Australasian Medical Journal, 6(11), (pp. 673). [Abstract]

Kemp, G., Meffan, P., Fry, D., Krishnaprasad, K., Heaphy, B., Day, A. S., & Gearry, R. B. (2013). The descriptive epidemiology of inflammatory bowel disease in Nelson, New Zealand. New Zealand Medical Journal, 126(1387). Retrieved from http://www.nzma.org.nz/journal

Magon, N. J., Turner, R., Dickerhof, N., Gearry, R., Hampton, M., Sly, P., & Kettle, A. (2013). Oxidation of methionine in calprotectin by neutrophils in the airways of children with cystic fibrosis. Free Radical Biology & Medicine, 65(Suppl. 2), (pp. S62-S63). doi: 10.1016/j.freeradbiomed.2013.10.535

Wright, E. K., De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K., Krejany, S., … Day, A. S., Gearry, R. B., & Desmond, P. V. (2013). Faecal calprotectin helps determine the need for post-operative colonoscopy in Crohn's disease: Prospective longitudinal endoscopic validation: Results from the POCER study. Journal of Gastroenterology & Hepatology, 28(Suppl. 2), (pp. 106). doi: 10.1111/jgh.12365_6

Conference Contribution - Poster Presentation (not in published proceedings)

Batt, C., Stamp, L., & Gearry, R. (2013, September). Prevalence of fructose malabsorption in patients with gout. Poster session presented at the Division of Health Sciences Research Forum: Foundations for Health: Otago Health Research, Christchurch, New Zealand.

McCombie, A., Gearry, R., & Mulder, R. (2013, September). Quality of life in IBD patients improves in the first six months post diagnosis. Poster session presented at the Division of Health Sciences Research Forum: Foundations for Health: Otago Health Research, Christchurch, New Zealand.

Magon, N. J., Gearry, R. B., Hampton, M. B., & Kettle, A. J. (2013, August). Oxidised calprotectin as a biomarker for inflammatory disease. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Ngu, J. H., Wallace, M., Merriman, T., Gearry, R. B., Stedman, C. A. M., & Roberts, R. (2013, June). Association of the HLA locus and TNF with type I autoimmune hepatitis susceptibility in New Zealand Caucasians. Poster session presented at the Asian Pacific Association for the Study of the Liver (APASL) Liver Week, Singapore.

Ngu, J. H., Gearry, R. B., Frampton, C. M., & Stedman, C. A. M. (2013, June). Environmental risk factors in autoimmune hepatitis: A population-based case control study. Poster session presented at the Asian Pacific Association for the Study of the Liver (APASL) Liver Week, Singapore.

Conference Contribution - Verbal presentation and other Conference outputs

Gearry, R. (2013, November). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Verbal presentation at the New Zealand Society of Gastroenterology & New Zealand Nurses Organisation Gastroenterology Section Annual Scientific Meeting, Wellington, New Zealand.

Gearry, R. (2013, September). Diseases and disciplines: Weaving a clinical research tapestry. Verbal presentation at the Division of Health Sciences Research Forum: Foundations for Health: Otago Health Research, Christchurch, New Zealand.

2012

Journal - Research Article

Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., … Gearry, R., … and also Barclay, M., & Roberts, R. (2012). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature, 491(7422), 119-124. doi: 10.1038/nature11582

Eglinton, T. W., Barclay, M. L., Gearry, R. B., & Frizelle, F. A. (2012). The spectrum of perianal Crohn's disease in a population-based cohort. Diseases of the Colon & Rectum, 55(7), 773-777. doi: 10.1097/DCR.0b013e31825228b0

Lim, G., Viney, S. K., Chapman, B. A., Frizelle, F. A., & Gearry, R. B. (2012). A prospective study of endoscopist-blinded colonoscopy withdrawal times and polyp detection rates in a tertiary hospital. New Zealand Medical Journal, 125(1356). Retrieved from http://www.nzma.org.nz/journal

Lion, M., Gearry, R. B., Day, A. S., & Eglinton, T. W. (2012). The cost of paediatric and perianal Crohn's disease in Canterbury, New Zealand. New Zealand Medical Journal, 125(1349). Retrieved from http://www.nzma.org.nz/journal

Bentley, R. W., Keown, D. A., Gearry, R. B., Cameron, V. A., Keenan, J., Roberts, R. L., & Day, A. S. (2012). Vitamin D receptor polymorphisms in colorectal cancer in New Zealand: An association study. New Zealand Medical Journal, 125(1356). Retrieved from http://www.nzma.org.nz/journal

Meijer, B., Gearry, R. B., & Day, A. S. (2012). The role of S100A12 as a systemic marker of inflammation. International Journal of Inflammation, 2012, 907078. doi: 10.1155/2012/907078

Ngu, J. H., Gearry, R. B., Wright, A. J., & Stedman, C. A. M. (2012). Low incidence and prevalence of primary biliary cirrhosis in Canterbury, New Zealand: A population-based study. Hepatology International, 6(4), 796-800. doi: 10.1007/s12072-011-9329-0

Eglinton, T. W., Roberts, R., Pearson, J., Barclay, M., Merriman, T. R., Frizelle, F. A., & Gearry, R. B. (2012). Clinical and genetic risk factors for perianal Crohn's disease in a population-based cohort. American Journal of Gastroenterology, 107, 589-596. doi: 10.1038/ajg.2011.437

Ngu, J. H., Gearry, R. B., Frampton, C. M., & Stedman, C. A. M. (2012). Mortality and the risk of malignancy in autoimmune liver diseases: A population-based study in Canterbury, New Zealand. Hepatology, 55(2), 522-529. doi: 10.1002/hep.24743

Roberts, R. L., Gallo, L.-M. D., Barclay, M. L., Gómez-García, M., Cardeña, C., Merriman, T. R., Gearry, R. B., & Martin, J. (2012). Independent replication of an association of CNVR7113.6 with Crohn's disease in caucasians. Inflammatory Bowel Diseases, 18(2), 305-311. doi: 10.1002/ibd.21752

Journal - Research Other

Ngu, J. H., Gearry, R. B., & Stedman, C. A. M. (2012). Has primary sclerosing cholangitis associated with Crohn's disease a better outcome? Journal of Crohn's & Colitis, 6(9), 956. doi: 10.1016/j.crohns.2012.05.013

Gearry, R. B., & Falvey, J. D. (2012). Rescue therapy for steroid refractory acute severe ulcerative colitis: More choice, better outcomes? Journal of Gastroenterology & Hepatology, 27(3), 417-418. doi: 10.1111/j.1440-1746.2012.07063.x

Meijer, B., Gearry, R. B., & Day, A. S. (2012). S100A12 in EDTA plasma: A cautionary tale. Journal of Crohn's & Colitis, 6(9), 961. doi: 10.1016/j.crohns.2012.05.020

Gearry, R. B., & Dodgshun, A. J. (2012). The “hygiene hypothesis” in IBD. Journal of Crohn's & Colitis, 6(8), 869. doi: 10.1016/j.crohns.2012.04.010

Journal - Professional & Other Non-Research Articles

Ngu, J. H., Gearry, R. B., & Stedman, C. A. M. (2012). [Reply to letter to the editor Primary sclerosing cholangitis: The gut-liver axis]. Clinical Gastroenterology & Hepatology, 10(7), 819-820. doi: 10.1016/j.cgh.2012.04.006

Conference Contribution - Published proceedings: Abstract

Magon, N. J., Gearry, R. B., Hampton, M. B., & Kettle, A. J. (2012). Oxidised calprotectin as a biomarker for inflammatory disease. Proceedings of the Oxygen Theme Meeting. (pp. 8). Dunedin, New Zealand: University of Otago. Retrieved from https://www.otago.ac.nz/research/otago051864.pdf

Ngu, J., Gearry, R., Frampton, C., & Stedman, C. (2012). Predictors of advanced liver fibrosis and poor outcome in patients with autoimmune hepatitis: A population-based study. Gut, 61(Suppl. 3), (pp. A230). [Abstract]

Schultz, M., Lewis-Morris, T., Rowbotham, D., Whiteside, C., Bennett, S., Thomas, G., Inns, S., & Gearry, R. B. (2012). Outcomes of adalimumab therapy for Crohn's disease from five New Zealand hospitals. New Zealand Medical Journal, 125(1367). Retrieved from http://www.nzma.org.nz/journal

Falvey, J. D., Hoskin, T., Meijer, B., Ashcroft, A., Hampton, M. B., Day, A. S., & Gearry, R. B. (2012). Disease assessment in Ulcerative Colitis (UC): Data from the Novel Biomarkers in Inflammatory Bowel Disease (NBIBD) project cohort. New Zealand Medical Journal, 125(1367). Retrieved from http://www.nzma.org.nz/journal

Falvey, J. D., Munday, J. S., Keenan, J. I., Dyer, A. E., Gearry, R. B., & Hampton, M. B. (2012). Clinical assessment of murine Dextran Sodium Sulphate (DSS) colitis: Prospective validation of a novel scoring tool. New Zealand Medical Journal, 125(1367). Retrieved from http://www.nzma.org.nz/journal

Falvey, J. D., Hoskin, T., Meijer, B., Ashcroft, A., Hampton, M. B., Day, A. S., & Gearry, R. B. (2012). Disease assessment in Crohn's disease (CD): Data from the Novel Biomarkers in Inflammatory Bowel Disease (NBIBD) project cohort. New Zealand Medical Journal, 125(1367). Retrieved from http://www.nzma.org.nz/journal

Ngu, J. H., Gearry, R. B., Frampton, C. M., & Stedman, C. A. M. (2012). Environmental risk factors in autoimmune hepatitis: A population-based case control study. New Zealand Medical Journal, 125(1367). Retrieved from http://www.nzma.org.nz/journal

Ngu, J. H., Gearry, R. B., Frampton, C. M., & Stedman, C. A. M. (2012). Predictors of poor outcome in patients with autoimmune hepatitis: A population-based study. New Zealand Medical Journal, 125(1367). Retrieved from http://www.nzma.org.nz/journal

Conference Contribution - Poster Presentation (not in published proceedings)

McCombie, A., Gearry, R., & Mulder, R. (2012, September). Inflammatory bowel disease patient preferences for a computerised over face-to-face psychological intervention. Poster session presented at the Division of Health Sciences Research Forum: Health Matters: Research Excellence at Otago, Dunedin, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Kemp, R., Day, A., Nolan, A., Tannock, G., & Gearry, R. (2012, June). Who are we (Part I). Panel discussion at the Inaugural GutHealth Network Workshop, Dunedin, New Zealand.

2011

Journal - Research Article

Haines, M. L., Ajlouni, Y., Irving, P. M., Sparrow, M. P., Rose, R., Gearry, R. B., & Gibson, P. R. (2011). Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease. Inflammatory Bowel Diseases, 17(6), 1301-1307. doi: 10.1002/ibd.21458

Rossin, E. J., Lage, K., Raychaudhuri, S., Xavier, R. J., Tatar, D., Benita, Y., International Inflammatory Bowel Disease Genetics Constortium, including Roberts, R., Barclay, M., Gearry, R., … Daly, M. J. (2011). Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genetics, 7(1), e1001273. doi: 10.1371/journal.pgen.1001273

Rivas, M. A., Beaudoin, M., Gardet, A., Stevens, C., Sharma, Y., Zhang, C. K., … International Inflammatory Bowel Disease Genetics Consortium, including Barclay, M., Gearry, R., Roberts, R., … Daly, M. J. (2011). Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nature Genetics, 43(11), 1066-1073. doi: 10.1038/ng.952

Diaz-Gallo, L.-M., Espino-Paisán, L., Fransen, K., Gómez-García, M., van Sommeren, S., Cardeña, C., … Barclay, M. L., … Gearry, R. B., Roberts, R. L., … Merriman, T. R., … Martin, J. (2011). Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis. Inflammatory Bowel Diseases, 17(11), 2287-2294. doi: 10.1002/ibd.21630

Krishnaprasad, K., Andrews, J. M., Lawrance, I. C., Florin, T., Gearry, R. B., Leong, R. W. L., … Radford-Smith, G. L. (2011). Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study. Journal of Crohn's & Colitis, 6(3), 287-293. doi: 10.1016/j.crohns.2011.08.016

Ngu, J. H., Gearry, R. B., Wright, A. J., & Stedman, C. A. M. (2011). Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis. Clinical Gastroenterology & Hepatology, 9(12), 1092-1097. doi: 10.1016/j.cgh.2011.08.027

Morgan, A. R., Han, D.-Y., Lam, W.-J., Triggs, C. M., Fraser, A. G., Barclay, M., Gearry, R. B., … Ferguson, L. R. (2011). Genetic variations in matrix metalloproteinases may be associated with increased risk of ulcerative colitis. Human Immunology, 72, 1117-1127. doi: 10.1016/j.humimm.2011.08.011

Glubb, D. M., Gearry, R. B., Barclay, M. L., Roberts, R. L., Pearson, J., Keenan, J. I., McKenzie, J., & Bentley, R. W. (2011). NOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn's disease. World Journal of Gastroenterology, 17(23), 2829-2837. doi: 10.3748/wjg.v17.i23.2829

Anderson, C. A., Boucher, G., Lees, C. W., Franke, A., D’Amato, M., Taylor, K. D., … Barclay, M., … Roberts, R., … Gearry, R., … Rioux, J. D. (2011). Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nature Genetics, 43(3), 246-254. doi: 10.1038/ng.764

Roberts, R. L., Hollis-Moffatt, J. E., Gómez-García, M., Fransen, K., Ponsioen, C. Y., Crusius, B. A., … Merriman, T. R., Barclay, M. L., Gearry, R. B., & Alizadeh, B. Z. (2011). Association of the protein-tyrosine phosphatase nonreceptor type substrate 1 (PTPNS1) gene with inflammatory bowel disease. Inflammatory Bowel Diseases, 17(2), E19-E21. doi: 10.1002/ibd.21470

Gardiner, S. J., Gearry, R. B., Burt, M. J., Chalmers-Watson, T., Chapman, B. A., Ross, A. G., Stedman, C. A. M., … Barclay, M. L. (2011). Allopurinol might improve response to azathioprine and 6-mercaptopurine by correcting an unfavorable metabolite ratio. Journal of Gastroenterology & Hepatology, 26(1), 49-54. doi: 10.1111/j.1440-1746.2010.06489.x

van Asseldonk, D. P., Sanderson, J., de Boer, N. K. H., Sparrow, M. P., Lémann, M., Ansari, A., … Gearry, R. B., … on behalf of the Thiopurine Task Force Interest Group. (2011). Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease: Proceedings of the first Thiopurine Task Force meeting. Digestive & Liver Disease, 43(4), 270-276. doi: 10.1016/j.dld.2010.09.001

Journal - Professional & Other Non-Research Articles

Gearry, R. B. (2011). [Review of the book Clinical gastroenterology: A practical problem based approach (3rd edition)]. New Zealand Medical Journal, 124(1340). Retrieved from http://journal.nzma.org.nz/journal/124-1340/4819/content.pdf

Bentley, R. W., Keown, D., Merriman, T. R., Krishnan, M. R., Gearry, R. B., Barclay, M. L., Roberts, R. L., & Day, A. S. (2011). Vitamin D receptor gene polymorphism associated with inflammatory bowel disease in New Zealand males [Letter to the editor]. Alimentary Pharmacology & Therapeutics, 33(7), 855-856. doi: 10.1111/j.1365-2036.2011.04588.x

Conference Contribution - Published proceedings: Abstract

Ngu, J. J., Gearry, R. B., Frampton, C. M., & Stedman, C. A. (2011). Mortality of autoimmune liver diseases in Canterbury, New Zealand: A population-based study. Gastroenterology, 140(5, Suppl. 1), (pp. S-906-S-907). [Abstract]

Ngu, J. J. H., Gearry, R., Frampton, C., & Stedman, C. (2011). Risk of malignancy in autoimmune liver diseases: A population-based study in Canterbury, New Zealand. Journal of Gastroenterology & Hepatology, 26(Suppl. 5), (pp. 170). doi: 10.1111/j.1440-1746.2011.06898.x

Eglinton, T. W., Balasingam, A. G., Dixon, L., Gearry, R. B., & Frizelle, F. A. (2011). Magnetic resonance imaging (MRI) in perianal Crohn's disease (CD): Does it change intra-operative decision making? Colorectal Disease, 13(Suppl. s5), 320, (pp. 51). doi: 10.1111/j.1463-1318.2011.02656.x

Eglinton, T. W., Roberts, R. L., Pearson, J. F., Barclay, M. L., Ferguson, L. R., Han, D. Y., Frizelle, F. A., & Gearry, R. B. (2011). Clinical and genetic risk factors for perianal Crohn's disease (CD) in a population based cohort. Colorectal Disease, 13(Suppl. s5), 067, (pp. 12). doi: 10.1111/j.1463-1318.2011.02655.x

Thomas, G. R., & Gearry, R. B. (2011). Adalimumab for Crohn's Disease in clinical practice: The first 98 patients in Christchurch Hospital. New Zealand Medical Journal, 124(1347). Retrieved from http://journal.nzma.org.nz/journal/124-1347/5015/content.pdf

Eglinton, T. W., Balasingham, A., Dixon, L., Gearry, R. B., & Frizelle, F. A. (2011). Magnetic Resonance Imaging (MRI) in perianal Crohn's disease (CD): Does it change intra-operative decision making? New Zealand Medical Journal, 124(1347). Retrieved from http://journal.nzma.org.nz/journal/124-1347/5015/content.pdf

Ngu, J. H., Gearry, R. B., & Stedman, C. A. M. (2011). Young age at diagnosis is a strong predictor of advanced liver fibrosis in patients with autoimmune hepatitis: A population-based study. New Zealand Medical Journal, 124(1347). Retrieved from http://journal.nzma.org.nz/journal/124-1347/5015/content.pdf

Falvey, J. D., Munday, J. S., Keenan, J. I., Gearry, R. B., & Hampton, M. B. (2011). Assessing the efficacy of isothiocyanates in experimental colitis. New Zealand Medical Journal, 124(1347). Retrieved from http://journal.nzma.org.nz/journal/124-1347/5015/content.pdf

Wall, C., Skidmore, P., Gearry, R., Pearson, J., Parnell, W., & Joyce, P. (2011). Associations between psycho-social variables and dietary intake. Nutrition & Dietetics, 68(Suppl. 2), (pp. 6). [Abstract]

Diaz-Gallo, L.-M., Espino-Paisán, L., Fransen, K., Gómez-García, M., van Sommeren, S., Cardeña, C., … Barclay, M. L., … Gearry, R. B., Roberts, R. L., … Merriman, T. R., … Martin, J. (2011). Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis. Journal of Translational Medicine, 8(Suppl. 1), P2. doi: 10.1186/1479-5876-8-S1-P2

Ngu, J., Gearry, R., Frampton, C., & Stedman, C. (2011). Mortality of autoimmune liver diseases in Canterbury, New Zealand: A population-based study. Internal Medicine Journal, 41(Suppl. 2), (pp. 12-13). doi: 10.1111/j.1445-5994.2011.02486.x

Conference Contribution - Poster Presentation (not in published proceedings)

Eglinton, T. W., Roberts, R. L., Pearson, J., Ferguson, L., Han, D., Barclay, M. L., Frizelle, F. A., & Gearry, R. B. (2011, November). Clinical and genetic risk factors for Perianal Crohn's disease (CD) in a population based cohort. Poster session presented at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Dunedin, New Zealand.

Eglinton, T. W., Barclay, M. L., Frizelle, F. A., & Gearry, R. B. (2011, November). The spectrum of Perianal Crohn's disease in a population based cohort. Poster session presented at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Dunedin, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Gearry, R. (2011, August). GWAS, G WHIZZ: An ignorant approach to genetics? Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and Carney Symposium: New Zealand Annual Scientific Meeting, Christchurch, New Zealand.

Gearry, R. (2011, November). Extraintestinal manifestations of IBD. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Dunedin, New Zealand.

Gearry, R. (2011, November). Ulcerative colitis: New therapeutic approaches. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Dunedin, New Zealand.

Roberts, R., Zhang, M., Gearry, R. B., & Barclay, M. L. (2011, October). Non-synonymous single nucleotide polymorphisms in guanosine 5'-monophosphate synthetase associated with altered metabolism of azathioprine. Verbal presentation at the 19th United European Gastroenterology Week (UEGW), Stockholm, Sweden.

Roberts, R., Gearry, R. B., Barclay, M. L., Hollis-Moffatt, J. E., Merriman, T. R., Highton, J., Jenks, K., Harrison, A. A., & Stebbings, S. M. (2011, October). Specific Interleukin 23 receptor haplotype may confer protection against Crohn's disease while increasing risk of spondyloarthritis. Verbal presentation at the 19th United European Gastroenterology Week (UEGW), Stockholm, Sweden.

2010

Journal - Research Article

Franke, A., McGovern, D. P. B., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., … Roberts, R., … Barclay, M., … Gearry, R., … Parkes, M. (2010). Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nature Genetics, 42(12), 1118-1125. doi: 10.1038/ng.717

Weersma, R. K., Crusius, J. B. A., Roberts, R. L., Koeleman, B. P. C., Palomino-Morales, R., Wolfkamp, S., Hollis-Moffatt, J. E., … Gearry, R. B., Barclay, M. L., … Merriman, T. R., … Alizadeh, B. Z. (2010). Association of FcgR2a, but not FcgR3a, with inflammatory bowel diseases across three Caucasian populations. Inflammatory Bowel Diseases, 16(12), 2080-2089. doi: 10.1002/ibd.21342

Stewart, L. C., Day, A. S., Pearson, J., Barclay, M. L., Gearry, R. B., Roberts, R. L., & Bentley, R. W. (2010). SLC11A1 polymorphisms in inflammatory bowel disease and Mycobacterium avium subspecies paratuberculosis status. World Journal of Gastroenterology, 16(45), 5727-5731. doi: 10.3748/wjg.v16.i45.5727

Ngu, J. H., Bechly, K., Chapman, B. A., Burt, M. J., Barclay, M. L., Gearry, R. B., & Stedman, C. A. M. (2010). Population-based epidemiology study of autoimmune hepatitis: A disease of older women? Journal of Gastroenterology & Hepatology, 25(10), 1681-1686. doi: 10.1111/j.1440-1746.2010.06384.x

Eglinton, T., Reilly, M., Chang, C., Barclay, M., Frizelle, F., & Gearry, R. (2010). Ileal disease is associated with surgery for perianal disease in a population-based Crohn's disease cohort. British Journal of Surgery, 97(7), 1103-1109. doi: 10.1002/bjs.7031

Schultz, M., Gearry, R., Walmsley, R., Day, A. S., Fraser, A., Wyeth, J., Barclay, M., … Whiteside, C. (2010). New Zealand Society of Gastroenterology statement on the use of biological therapy in inflammatory bowel disease. New Zealand Medical Journal, 123(1314). Retrieved from http://journal.nzma.org.nz/journal/123-1314/4115/content.pdf

Bentley, R. W., Cleynen, I., Gearry, R. B., Barclay, M. L., Rutgeerts, P., Merriman, T. R., … Roberts, R. L., & Vermeire, S. (2010). Evidence that glioma-associated oncogene homolog 1 is not a universal risk gene for inflammatory bowel disease in Caucasians. Genes & Immunity, 11, 509-514. doi: 10.1038/gene.2010.15

Simms, L. A., Doecke, J. D., Roberts, R. L., Fowler, E. V., Zhao, Z. Z., McGuckin, M. A., … McCallum, R., … Barclay, M. L., Gearry, R. B., Merriman, T. R., … Radford-Smith, G. L. (2010). KCNN4 gene variant is associated with ileal Crohn's disease in the Australian and New Zealand population. American Journal of Gastroenterology, 105, 2209-2217. doi: 10.1038/ajg.2010.161

van Langenberg, D. R., Gearry, R. B., Wong, H.-L., Ward, M., & Gibson, P. R. (2010). The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea. Internal Medicine Journal, 40(12), 819-827. doi: 10.1111/j.1445-5994.2009.02102.x

Triggs, C. M., Munday, K., Hu, R., Fraser, A. G., Gearry, R. B., Barclay, M. L., & Ferguson, L. R. (2010). Dietary factors in chronic inflammation: Food tolerances and intolerances of a New Zealand Caucasian Crohn's disease population. Mutation Research: Fundamental & Molecular Mechanisms of Mutagenesis, 690, 123-138. doi: 10.1016/j.mrfmmm.2010.01.020

Ooi, C. J., Fock, K. M., Makharia, G. K., . . ., Gearry, R. B., & et al (2010). The Asia-Pacific consensus on ulcerative colitis. Journal of Gastroenterology & Hepatology, 25(3), 453-468. doi: 10.1111/j.1440-1746.2010.06241.x

Roberts, R. L., Topless, R. K. G., Phipps-Green, A. J., Gearry, R. B., Barclay, M. L., & Merriman, T. R. (2010). Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn's disease. Genes & Immunity, 11, 351-356. doi: 10.1038/gene.2010.11

Day, A. S., & Gearry, R. B. (2010). Rifaximin and Crohn's disease: A new solution to an old problem? Digestive Diseases & Sciences, 55, 877-879. doi: 10.1007/s10620-010-1140-6

Bentley, R. W., Pearson, J., Gearry, R. B., Barclay, M. L., McKinney, C., Merriman, T. R., & Roberts, R. L. (2010). Association of higher DEFB4 genomic copy number with Crohn's disease. American Journal of Gastroenterology, 105(2), 354-359. doi: 10.1038/ajg.2009.582

Eglinton, T. W., & Gearry, R. B. (2010). Clinical factors predicting disease course in Crohn's disease. Expert Review of Clinical Immunology, 6(1), 41-45. doi: 10.1586/eci.09.76

Gearry, R. B., Richardson, A. K., Frampton, C. M., Dodgshun, A. J., & Barclay, M. L. (2010). Population-based cases control study of inflammatory bowel disease risk factors. Journal of Gastroenterology & Hepatology, 25, 325-333. doi: 10.1111/j.1440-1746.2009.06140.x

Journal - Research Other

Roberts, R. L., Gearry, R. B., & Barclay, M. L. (2010). Allopurinol—thiopurine combination therapy in inflammatory bowel disease: Are there genetic clues to this puzzle? [Editorial]. Pharmacogenomics, 11(11), 1505-1508. doi: 10.2217/pgs.10.143

Evans, C., Chalmers-Watson, T. A., & Gearry, R. B. (2010). Medical Image: Combination NSAID-codeine preparations and gastrointestinal toxicity [Clinical correspondence]. New Zealand Medical Journal, 123(1324). Retrieved from http://journal.nzma.org.nz/journal/123-1324/4383/content.pdf

Gibson, P. R., & Gearry, R. B. (2010). Optimizing thiopurine therapy: More weight to the metabolite argument [Editorial]. Journal of Gastroenterology & Hepatology, 25(10), 1592-1594. doi: 10.1111/j.1440-1746.2010.06472.x

Newnham, E., Gearry, R., & Gibson, P. (2010). Factors associated with radiation exposure in patients with inflammatory bowel disease [Letter to the editor]. Alimentary Pharmacology & Therapeutics, 31, 534-535. doi: 10.1111/j.1365-2036.2009.04205.x

Bryant, D. L., Miles, C. J., & Gearry, R. B. (2010). Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease [Clinical correspondence]. New Zealand Medical Journal, 123(1313). Retrieved from http://journal.nzma.org.nz/journal/123-1313/4079/content.pdf

Hollis-Moffatt, J. E., Gearry, R. B., Barclay, M. L., Merriman, T. R., & Roberts, R. L. (2010). Consolidation of evidence for association of the KIAA1109-TENR-IL2-IL21 rs6822844 variant with Crohn's disease [Letter]. American Journal of Gastroenterology, 105(5), 1204-1205. doi: 10.1038/ajg.2010.34

Gearry, R. B., Day, A. S., Barclay, M. L., Leong, R. W. L., & Sparrow, M. P. (2010). Azathioprine and allopurinol: A two-edged interaction [Editorial]. Journal of Gastroenterology & Hepatology, 25(4), 653-655. doi: 10.1111/j.1440-1746.2010.06254.x

Journal - Professional & Other Non-Research Articles

Bernstein, C. N., Fried, M., Krabshuis, J. H., Cohen, H., Eliakim, R., Fedail, S., Gearry, R., … Watermeyer, G. (2010). World Gastroenterology Organization practice guidelines for the diagnosis and management of IBD in 2010. Inflammatory Bowel Diseases, 16(1), 112-124. doi: 10.1002/ibd.21048

Conference Contribution - Published proceedings: Abstract

Krishnaprasad, K., Andrews, J., Grafton, R., Lawrance, I., Florin, T., Leong, R., … Gearry, R., … Radford-Smith, G. (2010). Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal classification: How good are we? A multi-centre Australasian study. Journal of Gastroenterology & Hepatology, 25(Suppl. 3), (pp. A98). doi: 10.1111/j.1440-1746.2010.06455.x

Gearry, R. B., Radford-Smith, G., Bampton, P., & Lawrance, I. C. (2010). The risk of skin cancer development in IBD patients on azathioprine/6 mercaptopurine. Journal of Gastroenterology & Hepatology, 25(Suppl. 3), (pp. A85). doi: 10.1111/j.1440-1746.2010.06455.x

Doecke, J., Simms, L. A., Zhao, Z. Z., Huang, N., Hanigan, K., Croft, A., … Roberts, R. L., … Barclay, M. L., … Gearry, R. B., … Radford-Smith, G. L. (2010). Genetic susceptibility in IBD: Overlap between ulcerative colitis and Crohn's disease. Journal of Gastroenterology & Hepatology, 25(Suppl. 3), (pp. A84). doi: 10.1111/j.1440-1746.2010.06454.x

Gearry, R. B., Glubb, D. M., Hollis-Moffatt, J. E., Topless, R. K. G., Simms, L. A., Doecke, J. D., … Barclay, M. L., … Merriman, T. R., … Roberts, R. L. (2010). Extracellular matrix protein 1 is associated with ulcerative colitis but is not implicated in Crohn's disease. Journal of Gastroenterology & Hepatology, 25(Suppl. 3), (pp. A80). doi: 10.1111/j.1440-1746.2010.06454.x

Simms, L. A., Doecke, J., Huang, N., Zhao, Z. Z., Kristine, F. U., Roberts, R. L., Barclay, M. L., … Gearry, R. B., & Radford-Smith, G. L. (2010). Genotype markers predict time to first resection in Crohn's disease patients. Journal of Gastroenterology & Hepatology, 25(Suppl. 3), (pp. A82-A83). doi: 10.1111/j.1440-1746.2010.06454.x

Glubb, D. M., Pearson, J., Hollis-Moffatt, J. E., Topless, R. K. G., Merriman, T. R., Simms, L. A., … Barclay, M. L., … Gearry, R. B., … Roberts, R. L. (2010). Extracellular Matrix Protein 1 is associated with ulcerative colitis but is not implicated in Crohn's disease. New Zealand Medical Journal, 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4492/content.pdf

Roberts, R. L., Gearry, R. B., Barclay, M. L., Hollis-Moffatt, J. E., Merriman, T. R., Jenks, K., Schultz, M., & Stebbings, S. (2010). Specific Interleukin-23 receptor haplotype may confer protection against Crohn's disease while increasing risk of Spondyloarthritis. New Zealand Medical Journal, 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4492/content.pdf

Falvey, J. D., Bentley, R. W., Merriman, T. R., Hampton, M. B., Barclay, M. L., Gearry, R. B., & Roberts, R. L. (2010). Gene-gene interaction between Macrophage Migration Inhibitory Factor (MIF) and NOD2 alters susceptibility to ileal Crohn's disease. New Zealand Medical Journal, 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4492/content.pdf

Ngu, J. H., Gearry, R. B., Frampton, C., & Stedman, C. A. M. (2010). Mortality of autoimmune liver diseases in Canterbury, New Zealand: A population-based study. New Zealand Medical Journal, 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4492/content.pdf

Ngu, J. H., Gearry, R. B., & Stedman, C. A. M. (2010). Survey of autoimmune hepatitis management in New Zealand. New Zealand Medical Journal, 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4492/content.pdf

Magon, N. J., Gearry, R. B., Hampton, M. B., & Kettle, A. J. (2010). Oxidised calprotectin as a biomarker for inflammatory disease. Free Radical Biology and Medicine. 49(Suppl. 1), (pp. S169). doi: 10.1016/j.freeradbiomed.2010.10.479

Ngu, J. H., Wright, A., Gearry, R. B., Chapman, B. A., Burt, M. J., Barclay, M. L., & Stedman, C. A. M. (2010). Population-based epidemiology of primary sclerosing cholangitis in Canterbury, New Zealand. Journal of Gastroenterology and Hepatology. 25(Suppl. 2), (pp. A11). doi: 10.1111/j.1440-1746.2009.06462.x

Ngu, J. H., Wright, A., Gearry, R. B., Chapman, B. A., Burt, M. J., Barclay, M. L., & Stedman, C. A. M. (2010). Primary biliary cirrhosis in Canterbury, New Zealand: A population-based study. Journal of Gastroenterology and Hepatology. 25(Suppl. 2), (pp. A11). doi: 10.1111/j.1440-1746.2009.06462.x

Roberts, R. L., Gearry, R. B., & Barclay, M. L. (2010). Are there pharmacogenetic indicators for allopurinol combination therapy in inflammatory bowel disease? Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting and the 6th Annual Carney Pharmacogenomics Symposium. ASCEPT. Retrieved from http://www.ascept.org.nz/

Gearry, R. B., Kamm, M. A., Hart, A. L., Gabe, S. M., & Nightingale, J. M. (2010). Predictors of intestinal failure in inflammatory bowel disease. Proceedings of the European Crohn's and Colitis Organisation 5th Congress. ECCO. Retrieved from http://ecco10.ecco-ibd.eu/

Conference Contribution - Verbal presentation and other Conference outputs

Roberts, R., Gearry, R., Barclay, M., Hollis-Moffatt, J., Merriman, T., & Jenks, K. (2010, August). Specific Interleukin 23 receptor haplotype may confer protection against intestinal inflammation while increasing risk of joint inflammation in spondyloarthritis. Verbal presentation at the New Zealand Rheumatology Association Annual Scientific Meeting, Christchurch, New Zealand.

Gearry, R. (2010, October). Biomarkers in IBD: Are we there yet? Verbal presentation at the Gastroenterology Society of Australia (GESA) Annual Scientifc Meeting: Australian Gastroenterology Week (AGW), Gold Coast, Australia.

Gearry, R. (2010, October). The risk of skin cancer development in IBD patients on azathioprine/6 mercaptopurine. Verbal presentation at the Gastroenterology Society of Australia (GESA) Annual Scientifc Meeting: Australian Gastroenterology Week (AGW), Gold Coast, Australia.

Gearry, R. (2010, October). Extracellular matrix protein 1 is associated with ulcerative colitis but is not implicated in Crohn's disease. Verbal presentation at the Gastroenterology Society of Australia (GESA) Annual Scientifc Meeting: Australian Gastroenterology Week (AGW), Gold Coast, Australia.

2009

Journal - Research Article

Huebner, C., Ferguson, L. R., Han, D. Y., Philpott, M., Barclay, M. L., Gearry, R. B., & et al (2009). Nucleotide-binding oligomerization domain containing I (NODI) haplotypes and single nucleotide polymorphisms modify susceptibility to inflammatory bowel diseases in a New Zealand Caucasian population: A case-control study. BMC Research Notes, 2, 52. doi: 10.1186/1756-0500-2-52

Ferguson, L. R., Han, D. Y., Huebner, C., Petermann, I., Barclay, M. L., Gearry, R. B., … Demmers, P. S. (2009). Tumor necrosis factor receptor superfamily, member 1B haplotypes increase or decrease the risk of inflammatory bowel diseases in a New Zealand Caucasian population. Gastroenterology Research & Practice, 591704. doi: 10.1155/2009/591704

Petermann, I., Huebner, C., Browning, B. L., Gearry, R. B., Barclay, M. L., Kennedy, M., Roberts, R., … Han, D. Y., & Ferguson, L. R. (2009). Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort. Human Immunology, 70, 440-446. doi: 10.1016/j.humimm.2009.03.002

Huebner, C., Browning, B. L., Petermann, I., Han, D. Y., Philpott, M., Barclay, M., Gearry, R., … Ferguson, L. R. (2009). Genetic analysis of MDR1 and inflammatory bowel disease reveals protective effect of heterozygous variants for ulcerative colitis. Inflammatory Bowel Diseases, 15(12), 1784-1793. doi: 10.1002/ibd.21019

Frizelle, F. A., Ing, A., Gearry, R. B., Whitehead, M., Faragher, I. G., & Dobbs, B. (2009). Immunomodulation does not alter histology in resected Crohn's disease. Techniques in Coloproctology, 13(4), 295-300. doi: 10.1007/s10151-009-0538-7

Petermann, I., Triggs, C. M., Huebner, C., Han, D. Y., Gearry, R. B., Barclay, M. L., … Ferguson, L. R. (2009). Mushroom intolerance: A novel diet-gene interaction in Crohn's disease. British Journal of Nutrition, 102(4), 506-508. doi: 10.1017/s0007114509276446

Journal - Research Other

Gearry, R. B., & Irving, P. M. (2009). Biologics for inflammatory bowel diseases in the Asia-Pacific: Can we afford to use them, can we afford not to? [Editorial]. Journal of Gastroenterology & Hepatology, 24(7), 1160-1162. doi: 10.1111/j.1440-1746.2009.05896.x

Conference Contribution - Published proceedings: Abstract

Bentley, R. W., Pearson, J., Gearry, R. B., Barclay, M. L., McKinney, C., Merriman, T. R., & Roberts, R. L. (2009). Association of increased beta-defensin 2 genomic copy number with Crohn's disease. Proceedings of the GASTRO Conference. Retrieved from http://www.gastro2009.org/scien_prog/search.php?navId=244

Glubb, D. M., Hollis-Moffatt, J. E., Topless, R. K. G., Gearry, R. B., . . ., Barclay, M. L., … Merriman, T. R., … Roberts, R. L. (2009). Extracellular Matrix Protein 1 is associated with ulcerative colitis but is not implicated in Crohn's disease. Proceedings of the GASTRO Conference. Retrieved from http://www.gastro2009.org/scien_prog/search.php?navId=244

Bentley, R. W., Cleynen, I., Gearry, R. B., Barclay, M. L., Rutgeerts, P., Merriman, T. R., … Roberts, R. L., & Vermeire, S. (2009). Meta-analysis provides no evidence for glioma-associated oncogene homolog 1 as a risk factor for inflammatory bowel disease in Caucasians. Proceedings of the GASTRO Conference. Retrieved from http://www.gastro2009.org/scien_prog/search.php?navId=244

Barclay, M. L., Roberts, R. L., & Gearry, R. B. (2009). Using genetics of inflammatory bowel disease to develop new treatments: A different slant on pharmacogenetics. Proceedings of the 5th Annual Carney Pharmacogenomics Symposium. Retrieved from http://www.otago.ac.nz/christchurch/otago019049.pdf

Conference Contribution - Poster Presentation (not in published proceedings)

Tan, P., Miles, C., Lynch, T., Alderton, K., Waites, L., & Gearry, R. B. (2009, November). The use of Millipore filters is likely to lead to significant cost savings in the processing of endoscopic biopsies. Poster session presented at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Wellington, New Zealand.

Ngu, J. J. H., Wright, A., Gearry, R. B., Chapman, B. A., Burt, M. J., Barclay, M. L., & Stedman, C. A. M. (2009, November). Primary sclerosing cholangitis in Canterbury: High incidence and prevalence with reduced life expectancy. Poster session presented at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Wellington, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Ngu, J. J. H., Wright, A., Gearry, R. B., Chapman, B. A., Burt, M. J., Barclay, M. L., & Stedman, C. A. M. (2009, November). Population-based epidemiology of primary biliary cirrhosis in Canterbury, New Zealand. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Wellington, New Zealand.

Gearry, R. B., Hart, A. L., Gabe, S. M., Nightingale, J. M., & Kamm, M. A. (2009, November). Predictors on intestinal failure in inflammatory bowel disease. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Wellington, New Zealand.

Tan, P. K., Lawrance, I. C., Bampton, P. A., Andrews, J. M., Croft, A., Radford-Smith, G. L., … Gearry, R. B. (2009, November). Serious infective complications associated with anti-TNF alpha therapy in inflammatory bowel disease. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Wellington, New Zealand.

Ngu, J. J. H., Bechly, K., Gearry, R. B., Chapman, B. A., Burt, M. J., Barclay, M. L., & Stedman, C. A. M. (2009, November). Population-based epidemiology study of autoimmune hepatitis: A disease of older women? Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Wellington, New Zealand.

Film/Video/CD Rom

Fraser, R., MacAskill, M., Gearry, R., Roberts, R., Sellman, D., & Wright, S. (2009). The Body, the Research, the Professor: Irritable Bowel Disease, Parkinson's & Brain Research, Mental Health [Episode 6] [Film]. Christchurch, New Zealand: Canterbury Medical Research Foundation. Retrieved from http://www.cmrf.org.nz/Home/Videos/#vid1

2008

Journal - Research Article

James, S. L., Irving, P. M., Gearry, R. B., & Gibson, P. R. (2008). Management of distal ulcerative colitis: Frequently asked questions analysis. Internal Medicine Journal, 38, 114-119. doi: 10.1111/j.1445-5994.2007.01601.x

Barrett, J. S., Canale, K. E. K., Gearry, R. B., Irving, P. M., & Gibson, P. R. (2008). Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome. World Journal of Gastroenterology, 14(32), 5020-5024. doi: 10.3748/wjg.14.5020

Ferguson, L. R., Huebner, C., Petermann, I., Gearry, R. B., Barclay, M. L., Demmers, P., … Han, D. Y. (2008). Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World Journal of Gastroenterology, 14(29), 4652-4661. doi: 10.3748/wjg.14.4652

Sutherland, A. D., Gearry, R. B., & Frizelle, F. A. (2008). Review of fecal biomarkers in inflammatory bowel disease. Diseases of the Colon & Rectum, 51(8), 1283-1291. doi: 10.1007/s10350-008-9310-8

Ferguson, L. R., Browning, B. L., Huebner, C., Petermann, I., Shelling, A. N., Demmers, P., … Gearry, R. B., Barclay, M. L., & Philpott, M. (2008). Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population. Digestive & Liver Disease, 40(9), 723-730. doi: 10.1016/j.dld.2008.02.011

Gardiner, S. J., Gearry, R. B., Begg, E. J., Zhang, M., & Barclay, M. L. (2008). Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold. Clinical Gastroenterology & Hepatology, 6(6), 654-660. doi: 10.1016/j.cgh.2008.02.032

Leong, R. W. L., Gearry, R. B., & Sparrow, M. P. (2008). Thiopurine hepatotoxicity in inflammatory bowel disease: The role for adding allopurinol. Expert Opinion on Drug Safety, 7(5), 607-616. doi: 10.1517/14740330802393957

Roberts, R. L., Gearry, R. B., Bland, M. V., Sies, C. W., George, P. M., Burt, M., … Barclay, M. L., & Kennedy, M. A. (2008). Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activity. Pharmacogenetics & Genomics, 18(5), 434-438.

Tarrant, K. M., Barclay, M. L., Frampton, C. M. A., & Gearry, R. B. (2008). Perianal disease predicts changes in Crohn's disease phenotype: Results of a population-based study of inflammatory bowel disease phenotype. American Journal of Gastroenterology, 103(12), 3082-3093.

Gardiner, S. J., Gearry, R. B., Burt, M. J., Ding, S. L., & Barclay, M. L. (2008). Severe hepatotoxicity with high 6-methylmercaptopurine nucleotide concentrations after thiopurine dose escalation due to low 6-thioguanine nucleotides. European Journal of Gastroenterology & Hepatology, 20(12), 1238-1242. doi: 10.1097/MEG.0b013e3282ffda37

Browning, B. L., Annese, V., Barclay, M. L., Bingham, S. A., Brand, S., Büning, C., … Gearry, R. B., … Witt, H. (2008). Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts. Journal of Medical Genetics, 45(1), 36-42. doi: 10.1136/jmg.2007.050773

Bentley, R. W., Keenan, J. I., Gearry, R. B., Kennedy, M. A., Barclay, M. L., & Roberts, R. L. (2008). Incidence of Mycobacterium avium subspecies paratuberculosis in a population-based cohort of patients with Crohn's disease and control subjects. American Journal of Gastroenterology, 103(5), 1168-1172. doi: 10.1111/j.1572-0241.2007.01742.x

Roberts, R. L., Hollis-Moffatt, J. E., Gearry, R. B., Kennedy, M. A., Barclay, M. L., & Merriman, T. R. (2008). Confirmation of association of IRGM and NCF4 with ileal Crohn's disease in a population-based cohort. Genes & Immunity, 9(6), 561-565. doi: 10.1038/gene.2008.49

Roberts, R. L., Gearry, R. B., Kennedy, M. A., & Barclay, M. L. (2008). Beyond TPMT: Genetic influences on thiopurine drug responses in inflammatory bowel disease. Personalized Medicine, 5(3), 233-248. doi: 10.2217/17410541.5.3.233

Journal - Research Other

Kelly, A. P., Robb, B. J., & Gearry, R. B. (2008). Hypocalcaemia and hypomagnesaemia: A complication of Crohn's disease [Clinical correspondence]. New Zealand Medical Journal, 121(1287). Retrieved from http://journal.nzma.org.nz/journal/121-1287/3420/content.pdf

Gearry, R. B., & Day, A. S. (2008). Inflammatory bowel disease in New Zealand children: A growing problem [Editorial]. New Zealand Medical Journal, 121(1283). Retrieved from http://journal.nzma.org.nz/journal/121-1283/3285/content.pdf

Journal - Professional & Other Non-Research Articles

Schultz, M., & Gearry, R. B. (2008). [Independent commentary of published medical research]. IBD Research Review, (1). Retrieved from http://www.researchreview.co.nz/research_review_catalogue.cfm?ID=40

Conference Contribution - Published proceedings: Abstract

Roberts, R. L., Gearry, R. B., Zhang, M., Begg, E. J., & Barclay, M. L. (2008). Optimisation of methotrexate in inflammatory bowel disease patients. Proceedings of the 4th Annual Carney Pharmacogenomics Symposium. Retrieved from http://www.chmeds.ac.nz/research/carneycentre/symposium.htm

Gearry, R. B., Roberts, R. L., Kennedy, M. A., Zhang, M., & Barclay, M. L. (2008). Thiopurine metabolites, intermediate steps on the way to complete thiopurine pharmacogenetics. Proceedings of the 4th Annual Carney Pharmacogenomics Symposium. Retrieved from http://www.chmeds.ac.nz/research/carneycentre/symposium.htm

van Langenberg, D. R., Gearry, R. B., & Gibson, P. R. (2008). The role of faecal lactoferrin in the evaluation of hospitalised patients with diarrhoea. Gastroenterology. 134(4 (Suppl. 1)), (pp. A-674). [Abstract]

Lawrance, I. C., Bampton, P. A., Sparrow, M., Gearry, R. B., Leong, R. W., Andrews, J. M., … Radford-Smith, G. L. (2008). Serious infective complications associated with anti-TNFα therapy in inflammatory Bowel disease. Journal of Gastroenterology & Hepatology, 23(Suppl. 4), (pp. A195). doi: 10.1111/j.1440-1746.2008.05610.x

Frizelle, F., Gearry, R., & Barclay, M. (2008). Surgery for perianal disease in a population-based Crohn's disease cohort. Diseases of the Colon & Rectum. 51(5), (pp. 669). doi: 10.1007/s10350-008-9314-4

Frizelle, F., Barclay, M., & Gearry, R. (2008). Characteristics of resectional surgery in a population-based inflammatory bowel disease cohort. Diseases of the Colon & Rectum. 51(5), (pp. 671). doi: 10.1007/s10350-008-9314-4

Chalmers-Watson, T. A., Tarrant, K. M., Barclay, M., Shirley, P. M., Frampton, C. M. A., & Gearry, R. B. (2008). Prevalence of extra-intestinal manifestations of inflammatory bowel disease in a population-based cohort. Journal of Gastroenterology & Hepatology, 23(Suppl. 4), (pp. A221). doi: 10.1111/j.1440-1746.2008.05611.x

Gearry, R. B., Tarrant, K. M., Shirley, P. M., Frampton, C. M., & Barclay, M. L. (2008). Perianal disease predicts changes in Crohn's disease phenotype: Results of a population-based study of inflammatory bowel disease phenotype. Journal of Gastroenterology & Hepatology, 23(Suppl. 4), (pp. A178). doi: 10.1111/j.1440-1746.2008.05610.x

Barclay, M. L., Gardiner, S. J., Gearry, R. B., Burt, M. J., Chalmers-Watson, T., Chapman, B. A., … Stedman, C. A. M. (2008). Allopurinol may improve response to azathioprine and 6-mercaptopurine by correcting an unfavorable metabolite ratio. Journal of Gastroenterology and Hepatology. 23(Suppl. 4), (pp. A194). [Abstract]

Ngu, J. H., Bechly, K., Gearry, R. B., & Stedman, C. A. (2008). Epidemiology of autoimmune hepatitis in Canterbury, New Zealand: A retrospective population based-study. Hepatology. 48(4 (Suppl.)), (pp. 1094A-1095A). [Abstract]

Barclay, M. L., Gardiner, S. J., Gearry, R. B., Burt, M. J., Chalmers-Watson, T., Chapman, B. A., … Stedman, C. A. M. (2008). Allopurinol may improve response to azathioprine and 6-mercaptopurine by correcting an unfavourable metabolite ratio. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Annual Scientific Meeting. ASCEPT. Retrieved from http://phal.otago.ac.nz/ascept_docos/programme%202008.pdf

Conference Contribution - Poster Presentation (not in published proceedings)

Chalmers-Watson, T. A., Tarrant, K. M., Frampton, C. M., Barclay, M. L., & Gearry, R. B. (2008, November). Extra-intestinal manifestations of Inflammatory Bowel Disease in a population_based cohort. Poster session presented at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Rotorua, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Bentley, R., Glubb, D. M., Keenan, J. I., Gearry, R. B., Barclay, M. L., & Roberts, R. L. (2008, November). Mycobacterium Avium subsp. Paratuberculosis associated with Crohn's disease in New Zealand. Verbal presentation at the Medical Sciences Congress, Queenstown, New Zealand.

Roberts, R., Hollis-Moffatt, J. E., Gearry, R. B., Barclay, M. L., & Merriman, T. R. (2008, November). Genetics of inflammatory bowel disease and intestinal permeability. Verbal presentation at the Medical Sciences Congress, Queenstown, New Zealand.

Gearry, R. (2008, September). Newer biologicals in inflammatory bowel disease. Verbal presentation at the Asia Pacific Digestive Week, New Delhi, India.

Gearry, R. (2008, September). Hit hard and hit early with anti-TNF. Verbal presentation at the Asia Pacific Digestive Week, New Delhi, India.

Roberts, R. L., Gearry, R. B., Zhang, M., Begg, E. J., & Barclay, M. L. (2008, October). Optimisation of methotrexate in inflammatory bowel disease patients. Verbal presentation at the 4th Annual Carney Pharmacogenomics Symposium, Christchurch, New Zealand.

Gearry, R. B., Roberts, R. L., Kennedy, M. A., Zhang, M., & Barclay, M. L. (2008, October). Thiopurine metabolites, intermediate steps on the way to complete thiopurine pharmacogenetics. Verbal presentation at the 4th Annual Carney Pharmacogenomics Symposium, Christchurch, New Zealand.

Tarrant, K. M., Frampton, C. M., Barclay, M. L., & Gearry, R. B. (2008, November). Perianal disease predicts changes in Crohn's disease phenotype: Results of a population-based study of Inflammatory Bowel Disease phenotype. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Rotorua, New Zealand.

2007

Journal - Research Article

Irving, P. M., Gearry, R. B., Sparrow, M. P., & Gibson, P. R. (2007). Appropriate use of corticosteroids in Crohn's disease [Review article]. Alimentary Pharmacology & Therapeutics, 26, 313-329.

Browning, B. L., Huebner, C., Petermann, I., Demmers, P., McCulloch, A., Gearry, R. B., Barclay, M. L., … Ferguson, L. R. (2007). Association of DLG5 variants with inflammatory bowel disease in the New Zealand caucasian population and meta-analysis of the DLG5 R30Q variant. Inflammatory Bowel Diseases, 13(9), 1069-1076.

Browning, B. L., Huebner, C., Petermann, I., Gearry, R. B., Barclay, M. L., Shelling, A. N., & Ferguson, L. R. (2007). Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. American Journal of Gastroenterology, 102, 2504-2512.

Gearry, R. B., Ajlouni, Y., Nandurkar, S., Iser, J. H., & Gibson, P. R. (2007). 5-aminosalicylic acid (Mesalazine) use in Crohn's disease: A survey of the opinions and practice of Australian gastroenterologists. Inflammatory Bowel Diseases, 13(8), 1009-1015.

Newnham, E., Hawkes, E., Surender, A., James, S. L., Gearry, R., & Gibson, P. R. (2007). Quantifying exposure to diagnostic medical radiation in patients with inflammatory bowel disease: Are we contributing to malignancy? Alimentary Pharmacology & Therapeutics, 26, 1019-1024.

Roberts, R. L., Gearry, R. B., Hollis-Moffatt, J. E., Miller, A. L., Reid, J., Abkevich, V., … Merriman, T. R., Barclay, M. L., & Kennedy, M. A. (2007). IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. American Journal of Gastroenterology, 102, 2754-2761.

Roberts, R. L., Gearry, R. B., Barclay, M. L., & Kennedy, M. A. (2007). IMPDH1 promoter mutations in a patient exhibiting azathioprine resistance. Pharmacogenomics Journal, 7(5), 312-317.

Gearry, R. B., Roberts, R. L., Burt, M. J., Frampton, C. M. A., Chapman, B. A., Collett, J. A., Shirley, P., Allington, M. D. E., Kennedy, M. A., & Barclay, M. L. (2007). Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort. Inflammatory Bowel Diseases, 13(10), 1220-1227.

Journal - Research Other

Gardiner, S. J., Begg, E. J., Sau, A., Marinaki, A., Gearry, R. B., & Barclay, M. L. (2007). Thiopurine treatment in inflammatory bowel disease [Letter to the editor]. Clinical Pharmacokinetics, 46(9), 803-804.

Gearry, R. B., & Frizelle, F. A. (2007). Management of dysplasia in patients with ulcerative colitis by surgeons: Truth or speculation [Letter to the editor]. Gastrointestinal Endoscopy, 66(5), 1069-1070.

Gardiner, S. J., Gearry, R. B., Roberts, R. L., Zhang, M., Barclay, M. L., & Begg, E. J. (2007). Breast-feeding during maternal use of azathioprine [Comment]. Annals of Pharmacotherapy, 41(4), 719-720.

Conference Contribution - Published proceedings: Abstract

Gearry, R. B. (2007). IBD overview. Proceedings of the 3rd Annual Carney Pharmacogenomics Symposium. Retrieved from http://www.chmeds.ac.nz/research/carneycentre/symposium.htm

Barclay, M., Roberts, R., Gearry, R., & Kennedy, M. (2007). Inflammatory bowel disease pharmacogenetics. Proceedings of the 3rd Annual Carney Pharmacogenomics Symposium. Retrieved from http://www.chmeds.ac.nz/research/carneycentre/symposium.htm

Roberts, R. L., Gearry, R. B., Bland, M. V., Sies, C., George, P. M., Burt, M., Kennedy, M. A., & Barclay, M. L. (2007). Trinucleotide repeat variants in inflammatory bowel disease patients exhibiting ultra-high thiopurine S-methyltransferase activity. Proceedings of the 3rd Annual Carney Pharmacogenomics Symposium. Retrieved from http://www.chmeds.ac.nz/research/carneycentre/symposium.htm

Gardiner, S. J., Gearry, R. B., Begg, E. J., & Barclay, M. L. (2007). Thiopurine methyltransferase (TPMT) and thiopurine dose in inflammatory bowel disease (IBD). Proceedings of the 3rd Annual Carney Pharmacogenomics Symposium. Retrieved from http://www.chmeds.ac.nz/research/carneycentre/symposium.htm

Roberts, R. L., Gearry, R. B., Hollis-Moffatt, J. E., Miller, A. L., Reid, J., Abkevich, V., … Merriman, T. R., Barclay, M. L., & Kennedy, M. A. (2007). IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. New Zealand Medical Journal, 120(1266). Retrieved from http://journal.nzma.org.nz/journal/120-1266/2848/content.pdf

Ngu, J. H., Bechly, K., Gearry, R. B., Chapman, B. A., Burt, M. J., Barclay, M. L., & Stedman, C. A. M. (2007). Prevalence of autoimmune hepatitis in Canterbury, New Zealand: A retrospective population based survey. New Zealand Medical Journal, 120(1266). Retrieved from http://journal.nzma.org.nz/journal/120-1266/2848/content.pdf

Chang, H., Gearry, R. B., Reilly, M. J., Barclay, M. L., & Frizelle, F. A. (2007). Characteristics of resectional surgery in a population-based inflammatory bowel disease cohort. Gut. 56(Suppl. III), (pp. A81). [Abstract]

Roberts, R. L., Gearry, R. B., Hollis-Moffatt, J. E., Miller, A. L., Reid, J., Abkevich, V., … Merriman, T. R., Barclay, M. L., & Kennedy, M. A. (2007). IL23R R381Q & ATG16L1 T300A are associated with Crohn's disease in a population-based New Zealand Caucasian cohort. Gut. 56(Suppl. III), (pp. A19). [Abstract]

Barclay, M. L., Ailabouni, R., & Gearry, R. B. (2007). Complementary and alternative medicine use in IBD is determined by age, sex and socioeconomic status and is no different than in controls without IBD. Gut. 56(Suppl. III), (pp. A151). [Abstract]

Barclay, M. L., Shirley, P. M., Ailabouni, R., & Gearry, R. B. (2007). High immunomodulator use in inflammatory bowel disease in New Zealand. Gut. 56(Suppl. III), (pp. A151). [Abstract]

Bentley, R. W., Gearry, R. B., Keenan, J. I., Aitken, J. M., Kennedy, M. A., Barclay, M. L., & Roberts, R. L. (2007). Relative incidence of Mycobacterium avium subsp. paratuberculosis in a population-based cohort of Crohn's disease patients. Gut. 56(Suppl. III), (pp. A127). [Abstract]

Gearry, R. B., Frampton, C. M., Collett, J. A., Chapman, B. A., Burt, M. J., Shirley, P. M., & Barclay, M. L. (2007). Inflammatory bowel disease (IBD) related morbidity in a population-based cohort. Gut. 56(Suppl. III), (pp. A127). [Abstract]

Gearry, R. B., Irving, P. M., Nathan, D. M., Barrett, J. M., Shepherd, S. J., & Gibson, P. R. (2007). The effect of reduction of poorly absorbed, highly fermentable short-chain carbohydrates (FODMAPS) on the symptoms of patients with inflammatory bowel disease (IBD). Gut, 56(Suppl. III), (pp. A151-A152). [Abstract]

Reilly, M. J., Chang, Y., Gearry, R. B., Barclay, M. L., & Frizelle, F. A. (2007). Surgery for perianal disease in a population-based Crohn's disease cohort. Gut. 56(Suppl. III), (pp. A163). [Abstract]

Barrett, J. S., Canale, K. E. K., Gearry, R. B., Irving, P. M., & Gibson, P. R. (2007). The effect of probiotics on breath hydrogen patterns after lactulose, small intestinal permeability and symptoms in IBS patients with an early breath hydrogen rise: A proof of concept study. Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A291). doi: 10.1111/j.1440-1746.2007.05159.x

Brown, R. E., Hoar, J. A., Barclay, M. L., & Gearry, R. B. (2007). A cross-sectional study of nutritional markers in a population-based Crohn's disease (CD) cohort. Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A401). doi: 10.1111/j.1440-1746.2007.05163.x

Barrett, J. S., Gearry, R. B., Irving, P. M., Muir, J. G., Haines, M. L., & Gibson, P. R. (2007). Dietary FODMAPS increase delivery of water and fermentable substrates to the proximal colon. Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A405). doi: 10.1111/j.1440-1746.2007.05164.x

Lim, G., Syme, S. K., Anderson, K. J., Chapman, B. A., Frizelle, F. A., & Gearry, R. B. (2007). Colonoscopy withdrawal times and polyp detection rates: A New Zealand perspective. Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A327). doi: 10.1111/j.1440-1746.2007.05160.x

Haines, M. L., Rose, R., Sparrow, M., Irving, P., Zhang, M., Gearry, R., & Gibson, P. R. (2007). Thiopurine metabolite testing: Clinical utility in an Australian cohort of IBD patients with inadequately controlled disease. Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A322). doi: 10.1111/j.1440-1746.2007.05172.x

Haines, M. L., Gearry, R., Rose, R., & Gibson, P. R. (2007). A simple method for the determination of large bowel mucosal 5-ASA levels using high performance liquid chromatography. Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A296). doi: 10.1111/j.1440-1746.2007.05172.x

van Langenberg, D. R., Gearry, R. B., Wong, H. L., Ward, M., Parker, F., & Gibson, P. R. (2007). The role of faecal lactoferrin in the evaluation of hospitalised patients with diarrhoea. Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A293). doi: 10.1111/j.1440-1746.2007.05172.x

Gearry, R. B., Irving, P. M., Nathan, D. M., Barrett, J. S., Shepherd, S. J., & Gibson, P. R. (2007). The effect of reduction of poorly absorbed, highly fermentable short-chain carbohydrates (FODMAPs) on the symptoms of patients with inflammatory bowel disease (IBD). Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A292). doi: 10.1111/j.1440-1746.2007.05159.x

Bentley, R. W., Roberts, R. L., Gearry, R. B., Merriman, T. R., Kennedy, M. A., & Barclay, M. L. (2007). The GLI1 gene as a risk factor for ulcerative colitis GLI1. Proceedings of the American Society of Human Genetics 57th Annual Meeting. Retrieved from http://www.ashg.org/genetics/ashg/annmeet/2007/call/postersessionlisting.shtml

Reid, L. W., Headon, B., Gearry, R. B., Irving, P. M., & Gibson, P. R. (2007). Inconsistencies and inadequacies in the use and monitoring of immunomodulatory drugs in patients with inflammatory bowel disease. Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A285). doi: 10.1111/j.1440-1746.2007.05159.x

Gearry, R., Nolan, R., Roberts, R., Barclay, M., Kennedy, M. A., Patterson, A., … Nolan, D. (2007). HLA, TPMT and ITPA genotypes and susceptibility to azathioprine hypersensitivity reactions (HSR) in inflammatory bowel disease (IBD) patients. Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A304). doi: 10.1111/j.1440-1746.2007.05172.x

Roberts, R. L., Gearry, R. B., Hollis-Moffatt, J. E., Miller, A. L., Reid, J., Abkevich, V., … Merriman, T. R., Barclay, M. L., & Kennedy, M. A. (2007). IL23R R381Q & ATG16L1 T300A are associated with Crohn's disease in a population-based Caucasian cohort. Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A305). doi: 10.1111/j.1440-1746.2007.05172.x

Bentley, R. W., Gearry, R. B., Keenan, J. I., Aitken, J. M., Kennedy, M. A., Barclay, M. L., & Roberts, R. L. (2007). Relative incidence of Mycobacterium avium subsp. paratuberculosis in a population-based cohort of Crohn's disease patients. Journal of Gastroenterology and Hepatology. 22(Suppl. 3), (pp. A317). [Abstract]

Bentley, R. W., Roberts, R. L., Gearry, R. B., Merriman, T. R., Kennedy, M. A., & Barclay, M. L. (2007). The GLI1 gene as a risk factor for ulcerative colitis. Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A321). doi: 10.1111/j.1440-1746.2007.05172.x

Chang, Y.-H., Gearry, R. B., Reilly, M. J., Barclay, M. L., & Frizelle, F. A. (2007). Resectional surgery characteristics in a population-based inflammatory bowel disease (IBD) cohort. Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A317). doi: 10.1111/j.1440-1746.2007.05172.x

Reilly, M. J., Chang, Y.-H., Gearry, R. B., Barclay, M. L., & Frizelle, F. A. (2007). Surgery for perianal disease in a population-based Crohn's disease cohort. Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A318). doi: 10.1111/j.1440-1746.2007.05172.x

Hoar, J. A., Brown, R. E., Gearry, R. B., & Barclay, M. L. (2007). Audit of blood test monitoring for patients on azathioprine or 6-MP for inflammatory bowel disease. Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A278). doi: 10.1111/j.1440-1746.2007.05159.x

Barclay, M. L., Ailabouni, R., Shirley, P. M., & Gearry, R. B. (2007). Pattern of medication use in a population-based inflammatory bowel disease cohort in New Zealand. Journal of Gastroenterology & Hepatology, 22(Suppl. 3), (pp. A288). doi: 10.1111/j.1440-1746.2007.05159.x

Conference Contribution - Poster Presentation (not in published proceedings)

Gearry, R. B., Irving, P. M., Nathan, D. M., Barrett, J. S., Shepherd, S. J., & Gibson, P. R. (2007, November). The effect of reduction of poorly absorbed, highly fermentable short-chain carbohydrates (FODMAPs) on the symptoms of patients with inflammatory bowel disease (IBD). Poster session presented at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting combined with the RACP and IMSANZ, Christchurch, New Zealand.

Haines, M. L., Gearry, R., Rose, R., & Gibson, P. R. (2007, November). A simple method for the determination of large bowel mucosal 5-ASA levels using high performance liquid chromatography. Poster session presented at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting combined with the RACP and IMSANZ, Christchurch, New Zealand.

Reilly, M. J., Chang, Y.-H., Gearry, R. B., Barclay, M. L., & Frizelle, F. A. (2007, November). Surgery for perianal disease in a population-based Crohn's disease cohort. Poster session presented at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting combined with the RACP and IMSANZ, Christchurch, New Zealand.

Chang, Y.-H., Gearry, R. B., Reilly, M. J., Barclay, M. L., & Frizelle, F. A. (2007, November). Resection surgery characteristics in a population-based inflammatory bowel disease (IBD) cohort. Poster session presented at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting combined with the RACP and IMSANZ, Christchurch, New Zealand.

Gearry, R. B., Montgomery, S. M., Frampton, C. M., & Barclay, M. L. (2007, November). A systematic review of case-control studies assessing environmental factors associated with inflammatory bowel disease (IBD). Poster session presented at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting combined with the RACP and IMSANZ, Christchurch, New Zealand.

Brown, R. E., Hoar, J. A., Barclay, M. L., & Gearry, R. B. (2007, November). A cross-sectional study of nutritional markers in a population-based Crohn's disease (CD) cohort. Poster session presented at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting combined with the RACP and IMSANZ, Christchurch, New Zealand.

Hoar, J. A., Brown, R. E., Gearry, R. B., & Barclay, M. L. (2007, November). Audit of blood test monitoring for patients on azathioprine or 6-mp for inflammatory bowel disease. Poster session presented at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting combined with the RACP and IMSANZ, Christchurch, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Syme, S., Gearry, R., & Lim, G. (2007, November). Colonoscopy withdrawal times and polyp detection rates in New Zealand: A nursing perspective. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting combined with the RACP and IMSANZ, Christchurch, New Zealand.

Barclay, M. L., Roberts, R. L., Gearry, R. B., Zhang, M., & Kennedy, M. A. (2007, August). Novel gene mutations for enzymes in the thiopurine metabolic pathway in patients with inflammatory bowel disease and severe azathioprine resistance. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists (NZ) Annual Scientific Meeting, Auckland, New Zealand.

Bentley, R. W., Roberts, R. L., Gearry, R. B., Keenan, J. I., Kennedy, M. A., & Barclay, M. L. (2007, November). Relative incidence of Mycobacterium avium subsp. paratuberculosis in a New Zealand population-based cohort of patients with Crohn's disease. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting combined with the RACP and IMSANZ, Christchurch, New Zealand.

Roberts, R. L., Gearry, R. B., Bland, M. V., Sies, C. W., George, P. M., Burt, M., Kennedy, M. A., & Barclay, M. L. (2007, October). Promoter insertion in an inflammatory bowel disease patient exhibiting ultra-high thiopurine S-methyltransferase activity. Verbal presentation at the Joint Cold Spring Harbor Laboratory/Wellcome Trust Conference, Cold Spring Harbor, New York.

Ngu, J. H., Bechly, K., Gearry, R. B., Chapman, B. A., Burt, M. J., Barclay, M. L., & Stedman, C. A. M. (2007, November). Prevalence of autoimmune hepatitis in Canterbury, New Zealand: A retrospective population based survey. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting combined with the RACP and IMSANZ, Christchurch, New Zealand.

Gearry, R. B. (2007, September). IBD overview. Verbal presentation at the 3rd Annual Carney Pharmacogenomics Symposium, Christchurch, New Zealand.

Barclay, M., Roberts, R., Gearry, R., & Kennedy, M. (2007, September). Inflammatory bowel disease pharmacogenetics. Verbal presentation at the 3rd Annual Carney Pharmacogenomics Symposium, Christchurch, New Zealand.

Roberts, R. L., Gearry, R. B., Bland, M. V., Sies, C. W., George, P. M., Burt, M., Kennedy, M. A., & Barclay, M. L. (2007, September). Trinucleotide repeat variants in inflammatory bowel disease patients exhibiting ultra-high thiopurine S-methyltransferase activity. Verbal presentation at the 3rd Annual Carney Pharmacogenomics Symposium, Christchurch, New Zealand.

Gardiner, S. J., Gearry, R. B., Begg, E. J., & Barclay, M. L. (2007, September). Thiopurine methyltransferase (TPMT) and thiopurine dose in inflammatory bowel disease (IBD). Verbal presentation at the 3rd Annual Carney Pharmacogenomics Symposium, Christchurch, New Zealand.

Sheffield, L., Sparrow, M., Irving, P., Gibson, P., Catto-Smith, T., Macrae, F., … Gearry, R. (2007, September). Promoting use of pharmacogenomic testing by multicentre demonstration projects in teaching hospitals. Verbal presentation at the 3rd Annual Carney Pharmacogenomics Symposium, Christchurch, New Zealand.

Gearry, R. (2007, November). Medical strategies in the treatment of inflammatory bowel disease. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting combined with the RACP and IMSANZ, Christchurch, New Zealand.

Gearry, R. (2007, November). Biologicals in IBD. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting combined with the RACP and IMSANZ, Christchurch, New Zealand.

Roberts, R. L., Gearry, R. B., Hollis-Moffatt, J. E., Miller, A. L., Reid, J., Abkevich, V., … Merriman, T. R., Barclay, M. L., & Kennedy, M. A. (2007, November). IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting combined with the RACP and IMSANZ, Christchurch, New Zealand.

Intellectual Property

Roberts, R. L., Gearry, R. B., Barclay, M. L., & Kennedy, M. A. (2007). Method of identifying individuals at risk of thiopurine drug resistance and intolerance. International (PCT) Patent Application (PCT/NZ2007/000329).

Roberts, R. L., Gearry, R. B., Barclay, M. L., & Kennedy, M. A. (2007). Method of identifying individuals at risk of thiopurine drug resistance and intolerance. United States Patent Application (60/935367).

2006

Journal - Research Article

Gardiner, S. J., Gearry, R. B., Roberts, R. L., Zhang, M., Barclay, M. L., & Begg, E. J. (2006). Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. British Journal of Clinical Pharmacology, 62(4), 453-456.

Roberts, R. L., Gearry, R. B., Allington, M. D. E., Morrin, H. R., Robinson, B. A., & Frizelle, F. A. (2006). Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer. Cancer Research, 66(5), 2532-2535.

Gearry, R. B., Richardson, A., Frampton, C. M., Collett, J. A., Burt, M. J., Chapman, B. A., & Barclay, M. L. (2006). High incidence of Crohn's disease in Canterbury, New Zealand: Results of an epidemiologic study. Inflammatory Bowel Diseases, 12(10), 936-943.

Priest, V. L., Begg, E. J., Gardiner, S. J., Frampton, C. M., Gearry, R. B., Barclay, M. L., Clark, D. W., & Hansen, P. (2006). Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel disease. Pharmacoeconomics, 24(8), 767-781.

Gardiner, S. J., Gearry, R. B., Barclay, M. L., & Begg, E. J. (2006). Two cases of thiopurine methyltransferase (TPMT) deficiency: A lucky save and a near miss with azathioprine. British Journal of Clinical Pharmacology, 62(4), 473-476. doi: 10.1111/j.1365-2125.2005.02474.x

Journal - Research Other

Gearry, R. B., Lea, R. A., Roberts, R. L., Chambers, G. K., Barclay, M. L., & Kennedy, M. A. (2006). CARD15 allele frequency differences in New Zealand Maori: Ancestry specific susceptibility to Crohn's disease in New Zealand? [Letter]. Gut, 55, 580. doi: 10.1136/gut.2005.085464

Conference Contribution - Published proceedings: Full paper

Gearry, R. B. (2006). Faecal testing in inflammatory bowel disease. In A. Fraser, P. R. Gibson, T. Hibi, J.-M. Qian & J. Schölmerich (Eds.), Proceedings of the Falk Symposium 151: Emerging Issues in Inflammatory Bowel Diseases. (pp. 135-148). Dordrecht, The Netherlands: Springer. [Full Paper]

Conference Contribution - Published proceedings: Abstract

Gearry, R. B., Roberts, R. R., Richardson, A., Frampton, C. M. A., Kennedy, M. A., & Barclay, M. L. (2006). The prevalence and genetic determinants of inflammatory bowel disease (IBD) in Canterbury. New Zealand Medical Journal, 119(1231). Retrieved from http://journal.nzma.org.nz/journal/119-1231/1922/content.pdf

Kennedy, M. A., Roberts, R. R., Gearry, R. B., Barclay, M. L., Taylor, D. R., Begg, E. J., Clark, D. W. J., & Joyce, P. R. (2006). Pharmacogenetics and genomics ″Down Under″: Focus on asthma, inflammatory bowel disease, and major depression. Proceedings of the Pharmacogenomics Meeting. (pp. 11). NY: Cold Spring Harbor Laboratory. [Abstract]

Gardiner, S. J., Gearry, R. B., Begg, E. J., & Barclay, M. L. (2006). Thiopurine methyltransferase (TPMT) and thiopurine dose in inflammatory bowel disease (IBD). Proceedings of the Australian Health and Medical Research Congress. (pp. 247). Sydney, Australia: Australian Health and Medical Research Congress. [Abstract]

Gearry, R. B., Frampton, C. M., Collett, J. A., Chapman, B. A., Burt, M. J., Shirley, P., & Barclay, M. L. (2006). Inflammatory bowel disease (IBD) related morbidity in a population-based cohort. Journal of Gastroenterology & Hepatology, 21(Suppl. 4), (pp. A274). doi: 10.1111/j.1440-1746.2006.04687.x

Gearry, R. B., Richardson, A., Frampton, C. M., Chapman, B. A., Burt, M. J., Collett, J. A., & Barclay, M. L. (2006). High rate of Crohn's disease in Canterbury, New Zealand: Results of a population-based study. Gastroenterology. 130(4, Suppl. 2), (pp. A-622). [Abstract]

Gearry, R. B., Richardson, A., Frampton, C. M., Collett, J. A., Dodgshun, A., Chapman, B. A., Burt, M. J., & Barclay, M. L. (2006). Environmental factors associated with ulcerative colitis: A large population-based case-control study. Gastroenterology. 130(4, Suppl. 2), (pp. A-137). [Abstract]

Gearry, R. B., Roberts, R. L., Frampton, C. M., Burt, M. J., Collett, J. A., Chapman, B. A., Allington, M. D., Kennedy, M. A., & Barclay, M. L. (2006). From Vienna to Montreal: The impact of changes in IBD classification on CARD15 genotype-phenotype relationships in a population-based cohort. Gastroenterology. 130(4, Suppl. 2), (pp. A-586). [Abstract]

Gearry, R. B., Richardson, A., Frampton, C. M., Collett, J. A., Dodgshun, A., Chapman, B. A., Burt, M. J., & Barclay, M. L. (2006). Environmental factors associated with Crohn's disease: A population-based case-control study. Gastroenterology. 130(4, Suppl. 2), (pp. A-621). [Abstract]

Barclay, M. L., Gardiner, S. J., Gearry, R. B., Roberts, R. L., Zhang, M., & Begg, E. J. (2006). Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. Journal of Gastroenterology & Hepatology, 21(Suppl. 4), (pp. A252). doi: 10.1111/j.1440-1746.2006.04686.x

Gearry, R. B., Montgomery, S. M., Frampton, C. M., & Barclay, M. L. (2006). A systematic review of case-control studies assessing environmental factors associated with inflammatory bowel disease (IBD). Journal of Gastroenterology & Hepatology, 21(Suppl. 4), (pp. A261). doi: 10.1111/j.1440-1746.2006.04687.x

Gearry, R. B., Richardson, A., Frampton, C. M., Collett, J. A., Dodgshun, A., Chapman, B. A., Burt, M. J., & Barclay, M. L. (2006). Environmental factors associated with Crohn's disease: A population-based case-control study. Journal of Gastroenterology & Hepatology, 21(Suppl. 4), (pp. A270). doi: 10.1111/j.1440-1746.2006.04687.x

Gearry, R. B., Richardson, A., Frampton, C. M., Collett, J. A., Dodgshun, A., Chapman, B. A., Burt, M. J., & Barclay, M. L. (2006). Environmental factors associated with ulcerative colitis: A population-based case-control study. Journal of Gastroenterology & Hepatology, 21(Suppl. 4), (pp. A271). doi: 10.1111/j.1440-1746.2006.04687.x

Gearry, R. B., Roberts, R. L., Frampton, C. M., Burt, M. J., Collett, J. A., Chapman, B. A., Allington, M. D., Kennedy, M. A., & Barclay, M. L. (2006). From Vienna to Montreal: The impact of changes in IBD classification on CARD15 genotype-phenotype relationships in a population-based cohort. Journal of Gastroenterology & Hepatology, 21(Suppl. 4), (pp. A271). doi: 10.1111/j.1440-1746.2006.04687.x

Barclay, M. L., Ailabouni, R., Gearry, R. B., & Frampton, C. (2006). Complementary and alternative medicine use in IBD is determined by age, sex and socioeconomic status and is no different than in controls without IBD. Journal of Gastroenterology & Hepatology, 21(Suppl. 4), (pp. A251). doi: 10.1111/j.1440-1746.2006.04686.x

Conference Contribution - Poster Presentation (not in published proceedings)

Roberts, R. L., Gearry, R. B., Kennedy, M. A., & Barclay, M. L. (2006, November-December). Mutations in the guanosine 5'-monophosphate synthetase (GMPS) gene are associated with thiopurine resistance. Poster session presented at the Medical Sciences Congress, Rotorua, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Barclay, M. L., Ailabouni, R., Gearry, R. B., & Frampton, C. (2006, August-September). Complementary and alternative medicine use in inflammatory bowel disease (IBD) is determined by age, sex and socioeconomic status and is no different than in controls without IBD. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists (New Zealand) Annual Scientific Meeting, Auckland, New Zealand.

Gearry, R., Frampton, C., Collett, J., Chapman, B., Burt, M., Shirley, P., & Barclay, M. (2006, November). Inflammatory bowel disease (IBD) related morbidity in a population-based cohort. Verbal presentation at the New Zealand Society of Gastroenterology NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Blenheim, New Zealand.

Gardiner, S. J., Gearry, R. B., Begg, E. J., & Barclay, M. L. (2006, August-September). Thiopurine methyltransferase (TPMT) and thiopurine dose in inflammatory bowel disease (IBD). Verbal presentation at the Australasian Society of Clinical Experimental Pharmacologists & Toxicologists (New Zealand) Annual Scientific Meeting, Auckland, New Zealand.

Roberts, R., Gardiner, S. J., Gearry, R. B., Bockett, N., & Barclay, M. L. (2006, August-September). Do mutations within inosine triphosphatase predict early intolerance to azathioprine? Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists (New Zealand) Annual Scientific Meeting, Auckland, New Zealand.

2005

Journal - Research Article

Gearry, R. B., & Barclay, M. L. (2005). Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. Journal of Gastroenterology & Hepatology, 20(8), 1149-1157.

Sies, C., Florkowski, C., George, P., Gearry, R., Barclay, M., Harraway, J., … Walmsley, T. (2005). Measurement of thiopurine methyl transferase activity guides dose-initiation and prevents toxicity from azathioprine. New Zealand Medical Journal, 118(1210). Retrieved from http://journal.nzma.org.nz/journal/118-1210/1324/content.pdf

Gearry, R., Barclay, M., Florkowski, C., George, P., & Walmsley, T. (2005). Faecal calprotectin: The case for a novel non-invasive way of assessing intestinal inflammation [Viewpoint]. New Zealand Medical Journal, 118(1214). Retrieved from http://journal.nzma.org.nz/journal/118-1214/1444/content.pdf

Gearry, R. B., Barclay, M. L., Roberts, R. L., Harraway, J., Zhang, M., Pike, L. S., George, P. M., & Florkowski, C. M. (2005). Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: Early experience of use in clinical practice. Internal Medicine Journal, 35, 580-585.

Journal - Research Other

Gearry, R. B., Aitken, J. M., Roberts, R. L., Ismail, S. L., Keenan, J., & Barclay, M. L. (2005). Gastrointestinal: Mycobacterium avium paratuberculosis and Crohn's disease. Journal of Gastroenterology & Hepatology, 20(12), 1943. doi: 10.1111/j.1440-1746.2005.04187.x

Conference Contribution - Published proceedings: Abstract

Roberts, R. L., Gearry, R. B., Barclay, M. L., & Kennedy, M. A. (2005). Interim CARD15 genotype results from a population-based study of Inflammatory Bowel Disease. European Journal of Human Genetics, 13(Suppl. 1), (pp. 304). [Abstract]

Conference Contribution - Poster Presentation (not in published proceedings)

Barclay, M. L., Roberts, R. L., Gearry, R. B., & Kennedy, M. A. (2005, September). Interim CARD15 genotype results from a population-based study of inflammatory bowel disease in New Zealand. Poster session presented at the World Congress of Gastroenterology, Montréal, Canada.

Barclay, M. L., Gearry, R. B., Frampton, C. M. A., Richardson, A. K., & Dodgshun, A. (2005, September). Increasing duration of breastfeeding is associated with a decreasing risk of Crohn's disease in later life. Poster session presented at the World Congress of Gastroenterology, Montréal, Canada.

Conference Contribution - Verbal presentation and other Conference outputs

Gearry, R., Roberts, R., Richardson, A., Frampton, C., Kennedy, M., & Barclay, M. (2005, November). The epidemiology and genetic determinants of inflammatory bowel disease (IBD) in Canterbury. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Hamilton, New Zealand.

Barclay, M., Gearry, R., Frampton, C., Richardson, A., & Dodgshun, A. (2005, November). Increasing duration of breastfeeding is associated with a decreasing risk of Crohn's disease in later life. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Hamilton, New Zealand.

Priest, V. L., Begg, E. J., Gardiner, S. J., Frampton, C. M. A., Gearry, R. B., Barclay, M. L., & Clark, D. W. J. (2005, August). Cost-efficacy of TPMT testing prior to azathioprine therapy. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Scientific Meeting, Wellington, New Zealand.

Gardiner, S. J., Begg, E. J., Gearry, R. B., & Barclay, M. L. (2005, August). Tacrolimus and azathioprine in breastfeeding: Are they safe? Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Scientific Meeting, Wellington, New Zealand.

2004

Journal - Research Article

Gearry, R. B., Roberts, R. L., Barclay, M. L., & Kennedy, M. A. (2004). Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine. Pharmacogenetics, 14(11), 779-781.

Gearry, R. B., Barclay, M. L., Burt, M. J., Collett, J. A., & Chapman, B. A. (2004). Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease. Pharmacoepidemiology & Drug Safety, 13(8), 563-567.

Roberts, R. L., Gearry, R. B., Barclay, M. L., & Kennedy, M. A. (2004). Rapid detection of common CARD15 variants in patients with inflammatory bowel disease. Molecular Diagnosis, 8(2), 101-105. doi: 10.1007/BF03260052

Roberts, R. L., Barclay, M. L., Gearry, R. B., & Kennedy, M. A. (2004). A multiplexed allele-specific polymerase chain reaction assay for the detection of common thiopurine S-methyltransferase (TPMT) mutations. Clinica Chimica Acta, 341(1-2), 49-53.

Frizelle, F. A., Gearry, R. B., Johnston, M., Barclay, M. L., Dobbs, B. R., Wise, C., & Troughton, W. D. (2004). Penile and clitoral stimulation for faecal incontinence: External application of a bipolar electrode for patients with faecal incontinence. Colorectal Disease, 6(1), 54-57. doi: 10.1111/j.1463-1318.2004.00543.x

Gearry, R. B., Wakeman, C. J., Barclay, M. L., Chapman, B. A., Collett, J. A., Burt, M. J., & Frizelle, F. A. (2004). Surveillance for dysplasia in patients with inflammatory bowel disease: A national survey of colonoscopic practice in New Zealand. Diseases of the Colon & Rectum, 47(3), 314-322.

Conference Contribution - Published proceedings: Abstract

Gearry, R., Barclay, M., Burt, M., Chapman, B., Collett, J., & George, P. (2004). Comparison of faecal calprotectin and clinical disease indices for assessing inflammation in Crohn's disease. New Zealand Medical Journal, 117(1195). Retrieved from http://journal.nzma.org.nz/journal/117-1195/916/content.pdf

2003

Journal - Research Article

Gearry, R. B., Barclay, M. L., Burt, M. J., Collett, J. A., Chapman, B. A., Roberts, R., & Kennedy, M. A. (2003). Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 18, 395-400.

Journal - Research Other

Gearry, R., Barclay, M., Gardiner, S., & Zhang, M. (2003). 6-thioguanine nucleotides and thiopurine methyltransferase activity: Important factors determining response to treatment and incidence of adverse effects from azathioprine and 6-MP [Letter]. New Zealand Medical Journal, 116(1178). Retrieved from http://journal.nzma.org.nz/journal/116-1178/531/content.pdf

Journal - Professional & Other Non-Research Articles

Keenan, J., Neal, S., & Gearry, R. B. (2003). Non-pylori Helicobacter [Medical image]. New Zealand Medical Journal, 116(1179). Retrieved from http://journal.nzma.org.nz/journal/116-1179/546/content.pdf

Gearry, R., Carne, P., & Frizelle, F. (2003). Takayasu's arteritis and ulcerative colitis [Case notes]. New Zealand Medical Journal, 116(1170). Retrieved from http://journal.nzma.org.nz/journal/116-1170/359/content.pdf

Gearry, R. B., Bramwell Cook, H., & Burt, M. J. (2003). Time for gastroscopy [Medical image]. New Zealand Medical Journal, 116(1168). Retrieved from http://journal.nzma.org.nz/journal/116-1168/309/content.pdf

Conference Contribution - Published proceedings: Abstract

Barclay, M. L., Gearry, R. B., Zhang, M., Roberts, R. L., Harraway, J., Pike, L., & Gardiner, S. J. (2003). Early New Zealand experience of monitoring TPMT activity and RBC 6-thioguanine nucleotides in patients on azathioprine or 6-MP. In E. A. Davis & C. G. Sobey (Eds.), Proceedings of the Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists. 10. Victoria, Australia: ASCEPT. [Abstract]

Wakeman, C. J., Gearry, R. B., Frizelle, F. A., Barclay, M. L., Chapman, B. A., Burt, M. J., & Collett, J. (2003). A survey of colonoscopic surveilance for dysplasia in patients with ulcerative colitis. ANZ Journal of Surgery, 73(Suppl.), (pp. A13-A14). doi: 10.1046/j.1445-2197.73.s.3.x

2002

Conference Contribution - Published proceedings: Abstract

Barclay, M. L., Gearry, R. B., Burt, M. J., & Collett, J. A. (2002). Azathioprine and 6-mercaptopurine adverse effects and TPMT genotype in patients with inflammatory bowel disease. Proceedings of the Australian Health and Medical Research Congress 2002. (pp. 1345). Australia: National Health & Medical Research Council. [Abstract]

Conference Contribution - Verbal presentation and other Conference outputs

Barclay, M. L., Gearry, R. B., Burt, M. J., Collett, J. A., Roberts, R. L., & Kennedy, M. A. (2002, November). Azathioprine and 6-mercaptopurine adverse effects and TPMT genotype in patients with inflammatory bowel disease. Verbal presentation at the Annual Meeting of the New Zealand Society of Gastroenterology, Auckland, New Zealand.

Barclay, M. L., Gearry, R. B., Burt, M. J., Collett, J. A., Roberts, R. L., & Kennedy, M. A. (2002, August). Azathioprine and 6-mercaptopurine adverse effects and TPMT genotype in patients with inflammatory bowel disease. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Meeting, Christchurch, New Zealand.